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Preface 
This thesis summarizes the results of a PhD project carried out at the Tech-
nical University of Denmark, Department of Environmental Engineering, 
from April 2012 to January 2016. The project was supervised by Assoc. Prof. 
Benedek Gy. Plósz, Prof. Stefan Trapp, and Assoc. Prof. Henrik R. Andersen. 
Project funding was provided by the Technical University of Denmark, De-
partment of Environmental Engineering. 
The thesis is organized in two parts: the first part puts into context the 
findings of the PhD in an introductive review; the second part consists of the 
papers listed below. These will be referred to in the text by their paper 
number written with the Roman numerals I-IV. 
I Polesel, F., Lehnberg, K., Dott, W., Trapp, S., Thomas, K.V., Plósz, 
B.G., 2015. Factors influencing sorption of ciprofloxacin onto activated 
sludge: Experimental assessment and modelling implications. 
Chemosphere 119, 105–111. 
 
II Polesel, F., Torresi, E., Loreggian, L., Escolá-Casas, M., Christensson, 
M., Bester, K., Plósz, B.G. (2015). Elimination of pharmaceuticals in pre-
denitrifying MBBR – Influence of exposure to primary substrate in 
single-stage and three-stage configurations. Manuscript in preparation. 
 
III Polesel, F., Andersen, H.R., Trapp, S., Plósz, B.G. (2015). Removal of 
antibiotics in biological wastewater treatment systems – A critical 
assessment of factors using the Activated Sludge Modelling Framework 
for Xenobiotics (ASM-X). Submitted manuscript. 
 
IV Polesel, F., Plósz, B.G., Trapp, S. (2015). From consumption to harvest: 
Environmental fate prediction of excreted ionizable trace organic 
chemicals. Water Research 84, 85–98. 
 
In this online version of the thesis, paper I-IV are not included but can be 
obtained from electronic article databases e.g. via www.orbit.dtu.dk or on 
request from DTU Environment, Technical University of Denmark, 
Miljoevej, Building 113, 2800 Kgs. Lyngby, Denmark, info@env.dtu.dk. 
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In addition, the following publications, not included in this thesis, were also 
concluded during this PhD study 
 Ramin, P., Libonati, A., Polesel, F., Causanilles Llanes, A., Emke, E., de 
Voogt, P., Plósz, B.G. Sorption and transformation of illicit drug bi-
omarkers in sewer systems: the role of suspended solids in raw wastewater. 
Manuscript in preparation. 
This PhD study also contributed to international conferences with the follow-
ing proceeding and conference papers: 
 Polesel, F., Plósz, B.G., Trapp, S. (2013). Activity-based fate modelling 
for risk assessment of three ionizable organic compounds (triclosan, furo-
semide, ciprofloxacin). Micropol & Ecohazard 2013, 8th IWA Specialist 
Conference on Assessment and Control of Micropollutants and Hazardous 
Substances in Water, Zurich, Switzerland, 16–23 June 2013. 
 Polesel, F., Lehnberg, K., Dott, W., Trapp, S., Thomas, K.V., Plósz, B.G. 
(2013). Modelling the fate of ciprofloxacin in activated sludge systems - 
The relevance of the sorption process. ICCE 2013, 14th EuCheMS Interna-
tional Conference on Chemistry and the Environment, Barcelona, Spain, 
25–28 June 2013. 
 Polesel, F., Lehnberg, K., Dott, W., Trapp, S., Thomas, K.V., Plósz, B.G. 
(2013). Modelling sorption of ciprofloxacin using the ASM-X framework 
– Evaluation of factors influencing activated sludge treatment and implica-
tions on environmental risk assessment. NORDIWA 2013, 13th Nordic 
Wastewater Conference, Malmö, Sweden, 8–10 October 2013. 
 Polesel, F., Langford, K.H., Trapp, S., Thomas, K.V., Plósz, B.G. (2014). 
Removal of pharmaceuticals in biological wastewater treatment systems: 
model generalisation and implications for environmental risk predictions.  
WWTmod 2014, 4th IWA/WEF Wastewater Treatment Modelling Semi-
nar, Spa, Belgium, 30 March–2 April 2014. 
 Ramin, P., Polesel, F., Andresson, G., Vezzaro, K., Sharma, A.K., Reid, 
M.J., Thomas, K.V., Mikkelsen, P.S., Plósz, B.G. (2014). Impacts of hy-
draulic residence time prediction and diurnal loading pattern on the estima-
tion of drug abuse in urban areas. ICUD 2014, 13th International Confer-
ence on Urban Drainage, Kuching, Malaysia, 7–11 September 2014. 
 
iii 
 Polesel, F., Langford, K.H., Trapp, S., Thomas, K.V., Plósz, B.G. (2014).  
Removal of pharmaceuticals in sewage treatment plants: A model generali-
sation to international data. 2014 IWA World Water Congress & Exhibi-
tion, Lisbon, Portugal, 21–26 September 2014. 
 Ramin, P., Causanilles, A., Polesel, F., Emke, E., de Voogt, P., Plósz, B.G. 
(2015). Abiotic and biofilm-mediated transformation of heroin biomarkers 
in wastewater under aerobic and anaerobic conditions. Testing the Waters, 
2nd International Conference on Wastewater-based drug epidemiology, 
Ascona, Switzerland, 11–15 October 2015. 
 Plósz, B.G., Polesel, F. (2015). Characterising the removal of trace organic 
chemicals in wastewater – Are we using the right tools? Micropol & Eco-
hazard 2015, 9th IWA Specialist Conference on Assessment and Control of 
Micropollutants and Hazardous Substances in Water, Singapore, Singa-
pore, 22–25 November 2015. 
 Polesel, F., Torresi, E., Loreggian, Escolá Casa, M., Bester, K., Plósz, 
B.G. (2015). Elimination of pharmaceuticals in single- and three-stage pre-
denitrifying MBBR. Micropol & Ecohazard 2015, 9th IWA Specialist 
Conference on Assessment and Control of Micropollutants and Hazardous 
Substances in Water, Singapore, Singapore, 22–25 November 2015. 
 Polesel, F., Plósz, B.G., Trapp, S. (2015). Modelling the fate of ionizable 
trace organic chemicals from consumption to food crops. Micropol & 
Ecohazard 2015, 9th IWA Specialist Conference on Assessment and 
Control of Micropollutants and Hazardous Substances in Water, Singapore, 
Singapore, 22–25 November 2015. 
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Summary 
As a result of widespread human activities, pharmaceuticals and biocides are 
ubiquitously present at trace levels in the environment. Large amounts of 
these substances, also identified as xenobiotic trace chemicals (XTCs), are 
released daily from: (i) households and healthcare facilities, following human 
consumption and disposal; (ii) husbandry and other analogous facilities, 
following veterinary consumption; and (iii) industrial facilities. A significant 
fraction of these emissions reaches municipal wastewater treatment plants 
(WWTPs), where XTCs undergo incomplete removal partly due to WWTP 
design limitations. These chemicals are thus eventually released to the 
environment, e.g. in freshwater bodies receiving WWTP effluents, 
representing a threat to living organisms. 
WWTPs have been generally identified as a major point source of XTC 
emissions to the environment. Nevertheless, due to the high number of 
marketed and consumed chemicals, and to the uncertainties associated to 
sampling and analytical methodologies, quantifying the elimination of XTCs 
during wastewater treatment still remains a challenge. Developing robust 
modelling tools to predict the fate of XTCs in WWTPs can help overcoming 
this challenge. However, in-depth understanding of mechanisms and 
processes, determining XTCs removal during wastewater treatment, is still 
required.  
This PhD thesis aimed at filling knowledge gaps in the field of XTC fate 
modelling during and beyond wastewater treatment. We aimed at improving 
the comprehension of XTC fate, and thus the predictive capabilities of fate 
models: (i) at process scale, with a focus on sorption and biological 
transformation of XTCs in biological treatment systems; (ii) in full-scale 
WWTPs, assessing the impact of retransformation and WWTP operation on 
XTC elimination; and (iii) in integrated WWTP-agricultural systems. 
Different modelling tools, suiting the specific purposes of our investigations, 
were developed, extended and/or innovatively applied. Fate models used as 
reference in this thesis include: the Activated Sludge Modelling framework 
for Xenobiotics (ASM-X); the generic WWTP model SimpleTreat Activity; 
and the dynamic soil-plant model for fate prediction in agricultural systems.    
Experimental and model-based observations were combined to assess 
sorption of ionizable XTCs onto activated sludge and XTC biotransformation 
in moving bed biofilm reactors (MBBRs). Most XTCs are in fact multispecies 
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chemicals, being present in neutral and/or ionized form in wastewater. We 
demonstrated that pH conditions and, to a lesser extent, iron salt dosing for 
chemical phosphorus removal can significantly affect solid-liquid partitioning 
of the zwitterionic antibiotic ciprofloxacin onto activated sludge. 
Electrostatic interactions and complexation are thus dominating sorption 
mechanisms. Under a range of pH, redox and iron salt dosing conditions, 
non-linear sorption (n=0.62–1.33) was observed. Extensions to traditional 
partitioning models were accordingly proposed for ciprofloxacin and other 
zwitterionic XTCs, accounting for: (i) high non-linearity of XTC sorption; or 
(ii) ionization with changing pH and different sorption potential of ionized 
species. Furthermore, XTCs are typically present in ng L-1 to µg L-1 
concentrations in wastewater, being referred to as non-growth substrates, and 
their biological degradation can be associated with microbial growth 
processes. In this PhD thesis, we assessed the influence of primary metabolic 
processes on XTC biotransformation in MBBR biofilm. Our investigation 
was performed by comparing biotransformation kinetics in pre-denitrifying 
MBBRs operated in single-stage and three-stage configurations. The latter 
configuration produced a prolonged biofilm exposure to organic electron 
donor (COD) loading and complexity tiered by segregated and integrated 
biofilm reactors, which significantly influenced kinetics of heterotrophic 
denitrification and XTC biotransformation. Biotransformation rate constants 
for a number of non-recalcitrant XTCs were found correlated to the 
denitrification potential of MBBR biofilm, suggesting that XTC degradation 
occurred via microbial co-metabolism. In addition, enhanced 
biotransformation kinetics was shown for a number of XTCs 
(sulfamethoxazole, erythromycin, atenolol) as compared to previous findings 
for conventional activated sludge.  
A number of factors have been described to influence the elimination of 
XTCs in full-scale WWTPs. Specifically, relevant impact was attributed to (i) 
solid residence time (SRT), at which biological treatment is operated; and (ii) 
the formation of XTCs due to, e.g., deconjugation of human metabolites. 
Many XTCs are in fact excreted by humans in the form of conjugates, which 
can undergo biotic retransformation to parent chemicals. In this PhD thesis, 
we specifically assessed the influence of retransformation processes and SRT 
on the fate of sulfamethoxazole in full-scale WWTPs. A methodology based 
on the comparison of ASM-X predictions and literature data was used. We 
demonstrated that the impact of retransformation during secondary 
wastewater treatment is determined by: (i) the size of WWTP catchments, 
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with major in-sewer retransformation expected in large catchments; (ii) the 
type of catchment (hospital or urban catchment). This evidence accordingly 
suggests an integrated approach to XTC fate assessment in wastewater 
systems (sewer networks and WWTPs). Furthermore, improved elimination 
of sulfamethoxazole was found and predicted in WWTPs operated at SRT 
greater than 16 d. Beyond this critical SRT, enhanced biotransformation 
kinetics may occur due to the enrichment of slow-growing organisms (e.g., 
specialist degraders) or mixed substrate utilization strategies. This finding 
supported our experimental evidence of enhanced sulfamethoxazole 
biotransformation kinetics in denitrifying MBBRs.  
As a result of incomplete biodegradation in WWTPs, XTCs persist in 
effluents and sewage sludge. Reuse of municipal biosolids and treated 
wastewater or use of freshwater for agricultural purposes eventually leads to 
XTC uptake into food crops. In this PhD thesis, we developed and tested a 
generic simulation tool to predict the fate of XTCs from consumption, 
through wastewater treatment and eventually to the uptake by winter wheat 
for a number of geographical scenarios in the European Union. The tool 
combined was specifically addressed for fate prediction of ionizable XTCs 
(the biocide triclosan, the diuretic furosemide and the antibiotic 
ciprofloxacin). Furosemide was found rather persistent to wastewater 
treatment (removal efficiency ≤ 40%) and to further undergo significant 
accumulation in wheat. Uptake of furosemide was predicted to increase 
(+20% of emissions to soil) when emissions to the soil-plant system occurred 
via freshwater irrigation, as compared to soil amendment with biosolids. Due 
to the scarce availability of experimental data, our model predictions indicate 
the need of deepening investigations of XTC fate in agricultural systems. 
Accumulation in food crops may result in indirect human exposure to XTCs 
via dietary intake, which can be eventually estimated using model 
predictions. The presented simulation tool can thus be used for pre-screening 
and priority setting of chemicals, and to explore the impact of additional XTC 
emission pathways (e.g., manure application, irrigation with reclaimed 
WWTP effluent) in terms of food crop accumulation.   
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Dansk sammenfatning 
Som et resultat af menneskelige aktiviteter er lægemidler og biocider 
allestedsnærværende i miljøet på sporstofniveau. Store mængder af disse stoffer, 
også kendt som miljøfremmede stoffer (på Engelsk XTCs: Xenobiotic Trace 
Chemicals), frigives dagligt fra: (i) husholdninger og sundhedsfaciliteter, som 
følge af indtagelse og bortskaffelse; (ii) dyrehold og tilsvarende faciliteter, som 
følge af dyrs indtagelse; og (iii) industrianlæg. En betydelig del af disse 
udledninger når frem til kommunale renseanlæg, hvor de miljøfremmede stoffer 
kun delvist bliver fjernet. I sidste ende udledes de miljøfremmede stoffer således 
til miljøet, f.eks. til ferskvandsområder der fungerer som recipienter for 
renseanlæg, hvor de udgør en trussel for levende organismer. 
Renseanlæg er blevet identificeret som en vigtig punktkilde for udledning af 
miljøfremmede stoffer til miljøet. På grund af det høje antal af markedsførte og 
forbrugt kemikalier, og de usikkerheder forbundet til prøveudtagning og 
analysemetoder, er der dog stadig store udfordringer forbundet med 
kvantificering af i hvor høj grad miljøfremmede stoffer bliver fjernet i 
forbindelse spildevandsrensning. Udvikling af robuste modelleringsværktøjer til 
at forudsige miljøfremmede stoffers skæbne i renseanlæg kan hjælpe med at 
overvinde denne udfordring. Men dybtgående forståelse af de mekanismer og 
processer, der styrer miljøfremmede stoffers fjernelse under spildevandsrensning, 
er stadig nødvendig. 
Målet med nærværende ph.d.-projekt var at udfylde huller i vores viden omkring 
modellering af miljøfremmed stoffers skæbne i renseanlæg og efterfølgende. Vi 
ville gerne forbedre forståelsen af miljøfremmede stoffers skæbne og dermed 
forbedre modellernes forudsigelsesevne: (i) ved processkalaen, med fokus på 
sorption og biologisk nedbrydning af miljøfremmede stoffer i biologiske 
renseanlæg; (ii) i fuldskala renseanlæg, hvor vi ville vurdere effekten af 
gendannelse og driften af renseanlægget på fjernelsesgraden; og (iii) i integrerede 
renseanlæg-landbrugssystemer. Forskellige modelleringsværktøjer, velegnede til 
hvert specifikt formål i undersøgelser, blev udviklet, udvidet eller anvendt 
innovativt. Følgende velkendte modeller blev anvendt: Activated Sludge 
Modelling framework for Xenobiotics (ASM-X); den generiske 
renseanlægsmodel SimpleTreat Activity; og den dynamiske jord-plante model til 
forudsigelse af kemikaliers skæbne i landbrugssystemer. 
Vi kombinerede eksperimentelle og modelbaserede observationer til at vurdere 
sorption af ioniserbare miljøfremmede stoffer til aktiveret slam og nedbrydning 
af miljøfremmede stoffer i ”moving bed”-biofilmreaktorer (MBBRs). De fleste 
x 
miljøfremmede stoffer er ioniserbare, og kan således være til stede i neutral og / 
eller ioniseret form i spildevand. Vi viste, at pH-betingelser, og i mindre grad, 
dosering af jernsalt til kemisk phosphorfjernelse, med sikkerhed påvirker 
faststof-væskepartitioneringen af det zwitterioniske antibiotikum ciprofloxacin i 
aktivt slam. Elektrostatiske interaktioner og kompleksdannelse er således 
dominerende sorptionsmekanismer. Vi observerede non-lineær sorption (n=0.62–
1.33) under forskellige pH-, redox- og jernsalt doseringsforhold. Vi foreslog 
derfor en udvidelse til traditionelle sorptionsmodeller for ciprofloxacin og andre 
zwitterioniske miljøfremmede stoffer, som beskriver ionisering som funktion af 
pH og ændret sorptionspotentiale for ioniserede stoffer. Miljøfremmede stoffer 
findes typisk i spildevand i koncetrationsniveauer mellem ng L-1 og ug L-1, 
hvilket medfører at de ikke kan bruges som substrater for vækst. Vi vurderede 
effekten af primære metaboliske processer i MBBRs på fjernelse af 
miljøfremmede stoffer. Undersøgelsen blev udført ved at sammenligne 
kinetikken i pre-denitrificerende MBBRs kørt i enkelttrins- og 
tretrinskonfigurationer. Sidstnævnte konfiguration produceret en langvarig 
udsættelse af biofilmen for faldende belastning med COD, hvilket påvirkede 
kinetikken af heterotrof denitrifikation og nedbrydning af miljøfremmede stoffer. 
Vi fandt at nedbrydningskonstanten for en række miljøfremmede stoffer var 
afhængig af denitrifikationspotentialet i biofilmen, hvilket indikerer, at 
nedbrydning af miljøfremmede stoffer var en co-metabolisk proces. 
Der er beskrevet en række faktorer der påvirker fjernelsen af miljøfremmede 
stoffer i fuldskala renseanlæg. Relevant effekt kan tilskrives (i) faststoffers 
opholdstid i den biologiske rensningsproces; og (ii) dannelse af miljøfremmede 
stoffer via f.eks. delvis nedbrydning af menneskelige metabolitter. Mange 
miljøfremmede stoffer udskilles af mennesker i form af metabolitter, som 
efterfølgende kan omdannes til moderstoffet igen. I dette projekt vurderede vi 
effekten af gendannelse og faststofsopholdstid på sulfamethoxazols skæbne i 
fuldskala renseanlæg. Vi brugte en metode baseret på sammenligning af ASM-X 
modelforudsigelser med værdier fra litteraturen. Vores undersøgelse viste, at 
effekten af gendannelse under sekundær spildevandsrensning er bestemt af: (i) 
størrelsen af renseanlæggets opland, idet høj grad af gendannelse i kloaksystemet 
kan forventes i store oplande; og (ii) typen af opland (med eller uden hospital). 
Dette peger på anvendelsen af en integreret tilgang til miljøfremmede stoffers 
skæbne-vurdering i spildevandsssystemer (kloaksystemer og rensningsanlæg). 
Endvidere forudså vi og fandt forbedret fjernelse af sulfamethoxazol i 
renseanlæg der kører med faststofsopholdstider på mere end 16 dage. Ved 
faststofsopholdstider over denne værdi kan der forventes forbedrede 
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nedbrydningskinetikker på grund af vækst i langsomtvoksende organismer (f.eks. 
specialiserede nedbrydere) eller på grund af blandede 
substratudnyttelsesstrategier. 
Miljøfremmede stoffer bliver som regel kun delvist nedbrudt i renseanlæg, og er 
derfor tilstede i udledninger fra renseanlæg og i spildevandsslammet. 
Udbringning af slam på marker og brug af renset spildevand eller ferskvand der 
modtager renset spildevand til kunstvanding af marker medfører i sidste ende 
optagelse af miljøfremmede stoffer i fødevareafgrøder. I dette projekt udviklede 
og afprøvede vi et generisk simuleringsværktøj til at forudsige miljøfremmede 
stoffers skæbne fra forbrug til optagelse i vinterhvede via nedbrydning i 
renseanlæg i en række geografiske scenarier i EU. Værktøjet kombinerede 
SimpleTreat Activity-modellen og den dynamiske jord-plante model, med særligt 
fokus på at forudsige skæbnen af ioniserbare stoffer. Ionisering har, som vist i 
vores første studie, store konsekvenser på faststof-væske partitioneringen, og på 
fordelingen ind i kornets væv. Vi udvalgte tre miljøfremmede stoffer som 
anvendes i store mængder, nemlig biocidet triclosan, det vanddrivende middel 
furosemid og antibiotikummet ciprofloxacin. Vi valgte tre reelle geografiske 
scenarier for områder i Den Europæiske Union og brugte gennemsnitlige 
forbrugsdata eller udledningsværdier fra forskellige EU-lande. Vi fandt at 
furosemid blev meget svagt nedbrudt i spildevandsrensning og blev signifikant 
akkumuleret i hvede. Optagelse af furosemid var større når udledning til jord-
plante-systemet opstod via kunstvanding med ferskvand, i forhold til udbringning 
af slam. Set i lyset af de få eksperimentelle data indikerer vores 
modelberegninger et behov for uddybende undersøgelser af miljøfremmede 
stoffers skæbne i landbrugssystemer. Ophobning i fødevareafgrøder kan resultere 
i indirekte eksponering af mennesker for miljøfremmede stoffer via kosten; 
denne eksponering kan estimeres ved hjælp modelsimuleringer. Det præsenterede 
simuleringsværktøj kan således anvendes til pre-screening og prioritering af 
kemikalier samt til at undersøge betydningen af miljøfremmede stoffers 
emmisionsveje (f.eks. udbringning af gødning irrigation med behandlet 
spildevand) i forbindelse med akkumulering i fødevareafgrøder.  
 
 
 
 
 
xii 
Table of contents 
Preface ............................................................................................................ i 
Acknowledgements ...................................................................................... iv 
Summary ...................................................................................................... vi 
Dansk sammenfatning ................................................................................. ix 
Table of contents ........................................................................................ xii 
Reader’s guide ............................................................................................ xv 
List of acronyms ........................................................................................ xvi 
List of symbols ......................................................................................... xviii 
1  Introduction ............................................................................................. 1 
1.1 Background and problem definition .............................................................. 1 
1.2 Objectives of the thesis ................................................................................. 4 
2  Fate of XTCs during wastewater treatment .......................................... 7 
2.1 Wastewater treatment configurations ............................................................ 7 
2.2 Fate processes ............................................................................................... 9 
2.2.1 Biotransformation/biodegradation .................................................................9 
2.2.2 Sorption/desorption ..................................................................................... 12 
2.2.3 Retransformation ......................................................................................... 14 
2.2.4 Ionization .................................................................................................... 17 
2.2.5 Other processes ........................................................................................... 18 
3  Modelling the fate of XTCs during (and beyond) wastewater 
treatment ..................................................................................................... 21 
3.1 Multimedia fugacity and activity models .................................................... 22 
3.1.1 Fugacity-based models ................................................................................ 22 
3.1.2 Activity-based models ................................................................................. 24 
3.2 Concentration-based models ....................................................................... 26 
3.3 Modelling fate processes: biotransformation .............................................. 29 
3.4 Beyond wastewater treatment: fate modelling in agricultural systems ........ 38 
4  Sorption of zwitterionic ciprofloxacin onto activated sludge ............. 41 
4.1 Properties of ciprofloxacin .......................................................................... 42 
4.2 Experimental methods and results ............................................................... 42 
4.3 Modelling implications ............................................................................... 45 
5  Biotransformation of XTCs in single- and three-stage pre-denitrifying 
MBBRs ........................................................................................................ 47 
5.1 Modelling removal kinetics in batch experiments ....................................... 49 
5.2 Influence of primary metabolism on XTC bio-transformation kinetics ....... 51 
xiii 
6  Factors influencing full-scale XTC removal: the case of 
sulfamethoxazole ........................................................................................ 53 
6.1 Influence of retransformation ..................................................................... 55 
6.1.1 Retransformation: during biological treatment or in upstream sewers? ........ 56 
6.2 Influence of SRT ........................................................................................ 58 
7  Beyond WWTPs: fate of XTCs in agricultural systems ...................... 61 
7.1 A generic fate modelling framework ........................................................... 61 
7.2 Uptake in winter wheat ............................................................................... 63 
8  Conclusions ............................................................................................ 67 
9  References .............................................................................................. 71 
10  Papers .................................................................................................... 91 
 
xiv 
  
xv 
Reader’s guide 
Chapter 1 presents a brief introduction on the main sources and pathways of 
XTC emission to the environment, describes the motivation and the objec-
tives of this PhD thesis. 
Chapters 2 and 3 present an overview of the current knowledge status on the 
fate of XTCs during wastewater treatment, following the release to sewer sys-
tems. A description is provided for: (i) wastewater treatment technologies and 
configurations, in which XTC removal has been traditionally assessed; (ii) 
relevant XTC fate processes; and (iii) approaches used and assumptions in-
troduced to model XTC fate (i.e. multimedia activity/fugacity models and 
concentration-based models). 
Chapter 4 focuses on the influence of pH and iron salt dosing on the parti-
tioning of ionizable XTCs onto activated sludge. Results are presented for the 
antibiotic ciprofloxacin, for which extensions to traditional partitioning mod-
els are proposed. 
Chapter 5 presents an assessment of XTC biotransformation kinetics in deni-
trifying moving bed biofilm reactors (MBBRs) in different configurations. 
Model structures used to describe XTC transformation kinetics are presented. 
The influence of primary metabolic processes (i.e., heterotrophic denitrifica-
tion) on XTC biotransformation is eventually discussed. 
Chapter 6 discusses the impact of retransformation processes and SRT on 
the elimination of the antibiotic sulfamethoxazole in full-scale wastewater 
treatment plants (WWTPs). The discussion is supported by a comparison be-
tween removal efficiency measurements from literature and model predic-
tions, using the Activated Sludge Modelling framework for Xenobiotics 
(ASM-X). 
Chapter 7 presents a model-based evaluation of XTC fate from human con-
sumption and excretion, through WWTPs, via irrigation or sewage sludge 
amendment up to the uptake in food crops at regional level. Plant uptake of 
three XTCs (triclosan, furosemide and ciprofloxacin) is compared, and the 
significance of XTC emission pathway to agricultural systems (fertilization 
or irrigation) is assessed. 
Mathematical notations (e.g., XTC concentrations) used in fate models are 
presented in Chapter 3. Equations in Chapters 2 and 4–6 are written using 
notation conventions presented for ASM-X. 
xvi 
List of acronyms 
A2O Anaerobic anoxic oxic 
ACD Advanced Chemistry Development 
ASM Activated sludge model 
ASM-X Activated sludge model for Xenobiotics 
BCF Bioconcentration factor 
BNR Biological nutrient removal 
BSM1 Benchmark simulation model no. 1 
BOD Biochemical oxygen demand 
CAS Conventional activated sludge 
COD Chemical oxygen demand 
DCM Dissolved and colloidal matter 
DNP Denitrification potential 
DO Dissolved oxygen 
E1 Estrone 
E2 17-β-estradiol 
EBPR Enhanced biological phosphorus removal 
EC European Community 
EEC European Economic Community 
EMEA European Medicines Evaluation Agency 
EPS Extracellular polymeric substance 
EU European Union 
EUSES European Union System for Evaluation of Substances 
FBR Fixed bed reactor 
MBBR Moving bed biofilm reactor 
MBR Membrane bioreactor 
MW Molecular weight 
NADPH Nicotinamide adenine dinucleotide phosphate 
xvii 
PAH Polycyclic aromatic hydrocarbons 
REACH Registration, Evaluation, Authorisation and Restriction of 
Chemicals 
SRT Solid residence time 
TSS Total suspended solids 
VSS Volatile suspended solids 
WHO World Health Organization 
WWTP Wastewater treatment plant 
XTC Xenobiotic trace chemical 
 
 
  
xviii 
List of symbols 
0 Referring to uncharged species 
+ Referring to cationic species 
- Referring to anionic species 
± Referring to zwitterionic species 
at Activity 
B Bulk activity capacity 
C Xenobiotic concentration 
CLI Aqueous parent xenobiotic concentration 
CCJ Aqueous retransformable xenobiotic concentration 
CSL Sorbed parent xenobiotic concentration 
D Octanol-water distribution coefficient 
F Fugacity 
F/M Food-to-microorganism ratio 
Fe(III) Ferric ion 
foc Fraction of organic carbon 
KS Half-saturation coefficient (substrate) 
KC Half-saturation coefficient (xenobiotic) 
Kaw Dimensionless air-water partition coefficient 
kbio Biotransformation rate constant 
k’bio Biotransformation rate 
kdec Retransformation rate constant 
kdes Desorption rate 
Kd Solid-liquid partition coefficient 
Kf Freundlich partition coefficient 
KI Inhibition coefficient 
Koc Solid-liquid partition coefficient normalized to organic carbon 
Kow Octanol-water partition coefficient 
xix 
Ka,HSA Partition coefficient to human serum albumin  
KZ Constant of tautomeric equilibrium 
L Lipid content in plant compartments 
M Mass load 
n Freundlich linearity parameter 
nLI,CJ Parent-to-retransformable xenobiotic ratio 
NO3-N Nitrate concentration as nitrogen 
NO2-N Nitrite concentration as nitrogen 
NOX Nitrogen oxide (nitrate and nitrite) concentration as nitrogen 
P Protein content in plant compartments 
pKa Ionization constant 
q Xenobiotic cometabolic utilization rate constant in the presence of 
growth substrate 
qC Xenobiotic cometabolic biotransformation rate constant in the 
presence of growth substrate 
S Substrate concentration 
T Xenobiotic cometabolic transformation yield 
Tref Reference temperature 
X Concentration of biomass or solids 
Y Microbial growth yield 
Z Fugacity capacity 
ϕ Ionic or neutral fraction 
µmax Maximum microbial growth rate 
θ Arrhenius coefficient 
η Xenobiotic removal efficiency 
ηLI Parent-based xenobiotic removal efficiency 
ηTOT Total (parent-based and retransformable) xenobiotic removal effi-
ciency 
 
 
xx 
 
 
 
 
1 
1 Introduction 
1.1 Background and problem definition  
The general classification of xenobiotic trace chemicals (XTCs) is used to 
identify man-made chemicals found in the environment, mostly including 
organic substances such as pharmaceuticals, biocides, illicit drugs, cosmetics, 
pesticides, herbicides and surfactants. These chemicals are largely products 
of industrial synthesis processes, and their ubiquitous presence in the envi-
ronment is essentially the consequence of human activities. 
Pharmaceuticals are widely consumed XTCs, finding application in human 
therapy and animal husbandry (Halling-Sørensen et al., 1998; Boxall et al., 
2003; Ternes et al., 2006). Biocides for human use include antimicrobial 
agents present in a wide range of consumer products (e.g., cosmetics, deter-
gents, clothing), medical products (e.g., disinfectants) and building materials 
(Singer et al., 2002; Bester, 2003; Bollmann et al., 2014). Release from sev-
eral sources contributes to their occurrence in the environment, as summa-
rized in Figure 1.1. Following administration to humans and animals, signifi-
cant fractions of these chemicals are excreted unchanged or in the form of 
metabolites. Excreted amounts eventually reach municipal wastewater treat-
ment plants (WWTPs) or are directly released to the environment (e.g., via 
manure application on soil). Additional emissions occur from industrial pro-
duction sites and from the (also improper) disposal of unutilized XTCs.  
In the last three decades, scientific research has focused on the release of 
pharmaceuticals following human consumption in households and healthcare 
facilities and on their fate during wastewater treatment. Municipal WWTPs 
have been accordingly recognized as a major point source of emissions, re-
sulting from limited elimination of trace chemicals (Richardson and Bowron, 
1985; Halling-Sørensen et al., 1998; Ternes, 1998; Kümmerer and Henninger, 
2003; Ternes et al., 2006). Particular attention has been dedicated to WWTP 
emissions to freshwater systems (Kolpin et al., 2002; Calamari et al., 2003; 
Johnson et al., 2008; Kasprzyk-Hordern et al., 2009; Ort et al., 2009).  
The environmental presence of pharmaceuticals and biocides at trace concen-
trations, with consequent living organism exposure, was associated to a num-
ber of concerns. Possible effects include: bioaccumulation; acute and chronic 
toxicity—also as a result of mixture or synergistic effects; and spread of anti-
biotic resistance (Halling-Sørensen et al., 1998; Jobling et al., 1998; Daugh-
ton and Ternes, 1999; Kümmerer and Henninger, 2003; Ternes et al., 2006; 
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Ågerstrand et al., 2015). Recently, antibiotic resistance was acknowledged as 
a major future threat for human health (WHO, 2014) 
 
Figure 1.1. Summary of the major sources of consumption and pathways of environmental 
release for pharmaceuticals and biocides. The research summarized in this PhD thesis pri-
marily focused on sources and recipients highlighted in blue. Although human consump-
tion and excretion was considered as the main emission source, we do not exclude that 
chemicals assessed in this study were released to WWTPs also by industrial and veterinary 
facilities (highlighted in pink). 
 
Characterizing the elimination of pharmaceuticals and biocides during 
wastewater treatment remains a challenge for researchers with respect to: (i) 
the number of substances produced, marketed and consumed worldwide; and 
(ii) sampling and analysis for XTCs in wastewater. Modelling the fate of 
trace chemicals during wastewater treatment can help overcoming these chal-
lenges and provide for additional benefits (e.g., support to decision-making). 
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Nevertheless, robust fate models require a system-level comprehension of 
XTC removal mechanisms. A lack of mechanistic understanding can still be 
identified in a number of areas, concerning XTCs fate in WWTPs: 
 Most of pharmaceuticals and biocides have one or more ionizable groups 
(Manallack, 2009; Franco et al. 2010) and can thus be present in charged 
form. XTC ionization is likely to influence chemical partitioning to solid 
matrices (Franco and Trapp, 2008; Franco et al., 2009) and biological deg-
radation (Gulde et al., 2014). 
 XTCs are present at trace levels in wastewater, i.e. in ng L-1 up to low µg 
L-1 concentration range, and typically cannot be utilized as growth sub-
strate by microbial populations. Their degradation may thus occur via sec-
ondary substrate utilization and cometabolism (Alexander, 1985; Rittmann, 
1992; Nyholm et al., 1996; Plósz et al., 2010a, 2012; Fischer and Majew-
ski, 2014) or mixed substrate utilization strategies (Egli, 2010; Tan et al., 
2013).  
 Pharmaceuticals can be formed during wastewater treatment via e.g., the 
degradation of respective excreted conjugated metabolites. These mecha-
nisms, known under the general term ‘retransformation’, have been charac-
terized for few substances (Ternes, 1998; Joss et al., 2004; Gomes et al., 
2009; Plósz et al., 2010a, 2012). Retransformation processes have been de-
scribed also in sewer systems (Jelic et al., 2015), influencing the loading of 
pharmaceuticals to WWTPs. Nevertheless, the impact of retransformation 
on the elimination of pharmaceuticals in WWTPs has not been fully clari-
fied yet. 
Eventually, a major and relevant endpoint of XTC emissions from WWTPs is 
represented by agricultural systems (Fig. 1.1). Due to the incomplete elimina-
tion during wastewater treatment, XTCs persist in WWTP effluents and sew-
age sludge. Reuse of municipal biosolids and treated wastewater for agricul-
tural purposes (fertilization, irrigation) is common practice worldwide 
(Ternes et al., 2007; Sabourin et al., 2012; Sato et al., 2013; Prosser et al., 
2014a), often encouraged at regulatory level (e.g., 86/278/EEC Directive in 
the European Union). Emissions also occur via irrigation with freshwater that 
contains XTC residues from WWTP effluents (Calderón-Preciado et al., 
2011). Reuse of treated (and untreated) sewage for crop irrigation leads to 
higher crop yields and is increasingly exploited in arid and semiarid areas as 
a result of water shortages (Calderón-Preciado et al., 2011; Goldstein et al., 
2014; Dalkmann et al., 2014). Besides release from WWTPs, amendment 
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with manure containing veterinary pharmaceuticals also results in emissions 
to agricultural soils (Boxall et al., 2003). Overall, these practices may deter-
mine uptake and subsequent accumulation of XTCs in food crops, eventually 
leading to dietary intake. Information on human exposure to XTCs via food 
crop consumption is scarce, and effects for human health are mostly unclear 
(Legind and Trapp, 2009; Prosser and Sibley, 2015; Malchi et al., 2015). Pre-
liminary evidences showed that ingestion of pharmaceuticals via contaminat-
ed food crops often exceeds intake via other environmental sources, such as 
groundwater or fish consumption.  
1.2 Objectives of the thesis 
The overall objective of this PhD thesis was to develop or innovatively apply 
suitable mathematic modelling tools to describe the fate of XTCs (Fig. 1.2): 
(i) at fate process scale, combining experimental observations and model-
based assessment (Paper I, Paper II); (ii) in full-scale WWTPs, using a 
model-based assessment methodology to evaluate the significance of factors 
influencing XTC elimination during biological treatment  (Paper III); (iii) at 
regional scale in integrated WWTP-agricultural systems (Paper IV). Model-
ling tools used as reference in this study include the Activated Sludge Model-
ling framework for Xenobiotics (ASM-X; Plósz et al., 2010a, 2012, 2013) 
(Paper I, II, III), the multimedia model Activity SimpleTreat (Franco et al., 
2011) and the dynamic soil-plant uptake model (Rein et al., 2011; Legind et 
al., 2012; Trapp and Eggen, 2013; Prosser et al., 2014b) (Paper IV). 
The specific objectives of this PhD study were:  
i. To evaluate experimentally the influence of pH and iron salt dosing, used 
for chemical phosphorus removal, on the sorption of ionizable XTCs onto 
activated sludge (Paper I) 
ii. To assess and/or simulate the impact of XTC ionization on sorption onto 
activated sludge (Paper I), full-scale WWTP elimination and plant uptake 
(Paper IV) and to evaluate the associated implications for fate modelling 
iii. To experimentally characterize the elimination of XTCs in pre-
denitrifying laboratory-scale moving bed biofilm reactors (MBBRs) and to 
provide a model-based evaluation of the influence of primary substrate load-
ing on XTC biotransformation (Paper II);  
iv. To evaluate and predict—using a model-based generalization methodolo-
gy (Plósz et al., 2012) and literature data—the impact of selected factors 
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(XTC retransformation, in-sewer reactions and solid residence time—SRT) 
on the full-scale XTC elimination during biological wastewater treatment 
(Paper III); 
v. To develop and test a modelling tool for fate prediction of XTCs from hu-
man consumption and excretion to plant uptake in agricultural systems, eval-
uating the impact of agricultural sludge reuse and irrigation on XTC accumu-
lation in food crops (Paper IV). The modelling tool was developed to further 
estimate potential risk from human exposure to XTCs via food crop intake 
and thus to support pre-screening and priority setting of potentially hazardous 
XTCs. 
 
Figure 1.2. Schematic presentation of the model-based research activities conducted in this 
PhD thesis: (i) at fate process scale (Paper I, II), combined to experimental investigation; 
(ii) in full-scale WWTPs (Paper III); and (iii) at regional scale, in integrated WWTP-
agricultural systems (Paper IV).  
 
Our investigations focused on commonly used biocides (triclosan) and phar-
maceuticals, i.e. antibiotics (ciprofloxacin, sulfonamides and macrolides), 
anti-inflammatory drugs (diclofenac, ibuprofen), beta-blockers (atenolol, 
metoprolol), diuretics (furosemide), antidepressants (venlafaxine) and X-ray 
contrast media (iohexol). 
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In this PhD thesis, the acronym XTC (xenobiotic trace chemicals) will be 
used from now on as common term for pharmaceuticals and biocides and 
their excreted metabolites.   
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2 Fate of XTCs during wastewater 
treatment 
2.1 Wastewater treatment configurations 
Significant amounts of pharmaceuticals are released from households, hospi-
tals and other facilities and eventually reach municipal wastewater treatment 
plants (WWTPs). WWTPs typically employ several wastewater treatment 
steps, from the removal of course solids to final polishing steps. This PhD 
thesis focused on the model-based and experimental assessment of XTC re-
moval during secondary treatment only (Paper I, II, III) and during primary 
and secondary treatment (Paper IV).  
Primary treatment typically consists of a sedimentation step (primary clarifi-
cation) for the removal of influent total suspended solids (TSS). Chemical 
dosing (coagulants/flocculants or iron/aluminium salts) can be performed to 
achieve increased solid removal efficiencies and pre-precipitation of influent 
phosphorus (Tchobanoglous et al., 2014; Wentzel et al., 2008). 
Secondary treatment includes a wide range of engineered biological systems 
for the removal of organic matter (measured as BOD/COD, biologi-
cal/chemical oxygen demand) and nutrients (nitrogen, phosphorus). Common 
treatment configurations investigated in this PhD thesis (through experi-
mental or model-based assessment or as a result of literature review) are pre-
sented in Figure 3. A general distinction is considered between suspended 
growth (activated sludge-based) and attached growth (biofilm-based) sys-
tems. In the former, activated sludge bioreactors are conventionally coupled 
to secondary sedimentation to separate and recirculate sludge biomass from 
treated effluent (Fig. 3a–c). Alternatively, submerged membranes are em-
ployed for biomass retention in bioreactors (membrane bioreactors—MBR, 
Fig. 3e). Solid residence time (SRT) or sludge age is the key operating pa-
rameter for suspended growth systems, allowing for the selection of a desired 
microbial function. Activated sludge systems for COD removal (SRT ≤ 5 d; 
Ekama and Wentzel, 2008) consist of single-stage aeration. Biological nutri-
ent removal (BNR) requires higher SRTs (≥ 8–10 d; Ekama and Wentzel, 
2008) for the growth of nitrifying bacteria. Most common examples of BNR 
systems are: (i) the Ludzack-Ettinger configuration with pre-denitrification 
(using influent COD as electron donor), nitrification and mixed liquor recir-
culation (Fig. 3b,e); (ii) the A2O (anaerobic/anox/aerobic) configuration for 
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enhanced biological phosphorus removal (EBPR; Fig. 3c). In these systems, 
phosphorus removal can be chemically achieved/enhanced via salt dosing 
(co- or post-precipitation; Wentzel et al., 2008). 
Biofilm systems are characterized by a number of advantages over conven-
tional activated sludge systems, namely prolonged biomass retention and re-
duced biomass separation requirements. Among these systems, increasing 
attention has been posed on moving bed biofilm reactors (MBBRs) (Øde-
gaard et al., 1994). In MBBRs, biomass is immobilized on suspended plastic 
carriers (Fig. 3d, detail), which undergo mixing by aeration or mechanical 
stirring. Common full-scale applications of MBBRs include nitrogen removal 
in BNR systems and effluent polishing (e.g., post-denitrification) (Rusten, 
2005; Ødegaard, 2006). A combined configuration is presented in Fig. 3d. 
 
Figure 2.1. Schematic representation of typical full-scale WWTP layouts employing pri-
mary and secondary treatment. Typical secondary treatment configurations assessed in this 
PhD thesis (experimentally, through modelling exercise or as a result of literature review) 
include: (a) aerated activated sludge system for COD removal (and nitrification) with sec-
ondary sedimentation; (b) pre-denitrifying Ludzack-Ettinger configuration with secondary 
sedimentation; (c) A2O configuration for enhanced biological phosphorus removal; (d) 
moving bed biofilm reactors (MBBR), employing plastic biofilm carriers (detail: Anox-
Kaldnes K1 carrier), in Ludzack-Ettinger configuration with post-denitrification; (e) pre-
denitrifying Ludzack-Ettinger configuration with nitrifying membrane bioreactor (MBR).  
 
(a) (b) 
(c) (d) 
(e) 
COD 
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2.2 Fate processes 
Elimination of influent XTCs during wastewater treatment is the combined 
result of a number of processes. Major processes responsible for XTC elimi-
nation will be described in the following sub-sections. 
2.2.1 Biotransformation/biodegradation 
Biotransformation and biodegradation are equivalent terms used to describe 
microbially-mediated transformations of organic xenobiotics to other chemi-
cal products. Subsequent steps of microbial transformation eventually lead to 
the complete mineralization of xenobiotics to inorganic carbon, nitrogen and 
water   (Schwarzenbach et al., 2003). Mineralization of XTCs rarely occurs in 
wastewater systems, with accumulation of multiple transformation products 
(see, e.g., Khunjar et al., 2011; Rubirola et al., 2014). Biotransformation and 
biodegradation are thus most appropriate to describe the biotic elimination of 
XTCs, and will be used within this PhD thesis. In this section, we will pre-
sent different mechanisms of biotransformation and factors influencing this 
process.  
Biotransformation of XTCs in ng L-1 to µg L-1 concentrations does not sup-
port biomass growth and energy requirements (Alexander, 1985; Rittmann, 
1992; Nyholm et al., 1996) and thus results from microbial cometabolism (i) 
in growing cells in the presence of growth/energy substrate and (ii) in resting 
cells in the absence of growth/energy substrate (Criddle, 1993). Case (ii) de-
scribes, e.g., cell maintenance via endogenous respiration. Cometabolic bio-
transformation further stems from the lack of specific enzymes catalysing 
defined transformation processes (Grady et al., 2011), being thus ‘fortuitous-
ly’ (Fischer and Majewski, 2014) catalysed by broad spectrum enzymes in 
autotrophic and heterotrophic populations (Helbling et al., 2010; Khunjar et 
al., 2011; Helbling et al., 2012).  
For a number of organic xenobiotics, biotransformation was described as a 
metabolic process supporting the growth of specialist degrader populations 
(detergent builders: Siegrist et al., 1989; endocrine disrupters: Lindblom et 
al., 2009). More recently, this hypothesis was tested by associating biodiver-
sity (Johnson et al., 2015) and taxonomic abundance (Helbling et al., 2015) to 
XTC biotransformation rates. Associations were demonstrated only for a lim-
ited number of XTCs (ranitidine, venlafaxine), being degraded via uncom-
mon transformation pathways. It was suggested that specialist degraders are 
responsible only for a limited number of rarely occurring transformations 
(Johnson et al., 2015; Helbling et al., 2015), whereas less rare transfor-
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mations are probably catalysed, via cometabolism, by commonly present non-
specific enzymes. 
Consequently, primary growth and energy substrates play a significant role in 
the biotransformation of XTCs. The presence of growth substrate, effectively 
supporting biomass growth, was shown to be beneficial for XTC biotrans-
formation in batch (Plósz et al., 2012) and continuous-flow experiments (Tan 
et al., 2013; Su et al., 2015). Nevertheless, growth substrate inhibition of 
XTC biotransformation was also reported (Joss et al., 2004; Plósz et al., 
2010a; Su et al., 2015; Mazioti et al., 2015), resulting from, e.g., competition 
for non-specific enzymes. 
Conversely, strongly limiting growth substrate availability was hypothesized 
to improve XTC biotransformation due to (i) reduced competitive inhibition 
effects; and/or (ii) expansion of biomass metabolic capabilities. Under oligo-
trophic conditions, microbial metabolism relies on the utilization of multiple 
substrates at low concentration (mixed substrate growth; Egli, 2010). 
Through broad catabolic enzyme expression, bacteria can utilize organic sub-
stances not typically used as growth substrates (‘metabolic expansion’; Ihssen 
and Egli, 2005; Egli, 2010). Adaptation to growth substrate limitation may 
lead to the selection of K-strategist populations (Koh et al., 2009). Under pro-
longed biomass starvation, enhanced biotransformation rate of the estrogen 
E1 was observed and attributed to mixed substrate utilization by hetero-
trophic bacteria (Tan et al., 2013). Improved biotransformation by biomass 
exposed to limiting substrate availability was further observed for estrogens 
(Koh et al., 2009; Ziels et al., 2014; Petrie et al., 2014) and pharmaceuticals 
(Falås et al., 2013). Even under strongly limiting conditions, the availability 
of alternative substrates can be beneficial for XTC biotransformation by sup-
porting catabolic enzyme induction (Egli, 2010). The type of available organ-
ic substrate can thus be influential. Increased biotransformation rate for E1 
was found in the presence of recalcitrant organic substrate—namely products 
of bacterial decay and lysis—arising from prolonged biomass starvation (Tan 
et al., 2015).  
Overall, there is limited information on the importance of growth substrate 
availability for the biological transformation of XTCs. Furthermore, most of 
available evidences refer to observations under aerobic conditions. In Paper 
II, we assessed XTC biotransformation by pre-denitrifying biomass exposed 
to different growth substrate availability and loading conditions. By testing 
the hypotheses presented above, we aimed at discriminating whether (i) 
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growth substrate supports XTC biotransformation as a result of cometabo-
lism; or (ii) strongly limiting substrate availability is beneficial for XTC bio-
transformation. 
Among other operational factors, SRT was hypothesized to influence XTC 
biotransformation capacity of suspended and attached biomass. Improved 
XTC biotransformation at increasing SRT was considered the result of in-
creased microbial diversity (e.g., enrichment of slowly growing bacteria) or 
of metabolic capabilities (e.g., mixed substrate growth) (Ternes et al., 2004b). 
Specifically, the positive influence of SRT on XTC elimination was consid-
ered to occur: (i) in the presence of nitrifiers (SRT > 5 d in fully aerobic sys-
tems and > 8–10 d in aerobic-anoxic systems; Ekama and Wentzel, 2008); 
and (ii) in systems with enhanced physical biomass retention, thus operating 
at extended SRTs (e.g., MBRs, MBBRs). Critical SRTs have been according-
ly identified with respect to the first (10 d; Clara et al., 2005a,b) and the sec-
ond case (e.g., 20 d for diclofenac; Plósz et al., 2012), at which increased 
XTC elimination was shown due to a step improvement in biotransformation 
kinetics. To date, however, no generalization on the impact of SRT could be 
made.  
XTC can be co-metabolized by ammonia oxidizing bacteria (AOB) via the 
broad-spectrum enzyme ammonia monooxygenase (AMO) (Vader et al., 
2000; Shi et al., 2004; Yi and Harper, 2007b). Enhanced XTC biotransfor-
mation in active and resting nitrifiying cultures was accordingly observed for 
estrogens and pharmaceuticals (e.g., Vader et al., 2000; Batt et al., 2006; 
Forrez et al., 2008; Khunjar et al., 2011; Sathyamoorthy et al., 2013). How-
ever, this could not be confirmed for all the XTCs assessed (Khunjar et al., 
2011; Sathyamoorthy et al., 2013). Conversely, the contribution of AOB to 
XTC biotransformation has been disputed (Gaulke et al., 2008) or deemed 
limited (e.g., McAdam et al., 2010; Majewsky et al., 2011a; Bagnall et al., 
2012; Helbling et al. 2012; Petrie et al., 2014a) as compared to heterotrophic 
bacteria.  
Operation at extended SRT in MBRs and biofilm reactors (e.g., MBBRs) may 
enhance XTC biotransformation due to (Joss et al., 2006b; Weiss and 
Reemtsma, 2008; Oulton et al., 2009; Le-Minh et al., 2010; Vuono et al., 
2014): (i) improved adaptation to trace chemicals; (ii) enrichment of slow 
growing organisms, capable of utilizing XTCs as a resource; (iii) reduced 
substrate availability from low food-to-microorganism (F/M) ratio, inducing 
the utilization of low concentration XTCs as substrates (mixed substrate me-
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tabolism: Egli, 2010). Improvement of XTC biotransformation and elimina-
tion in MBRs, as compared to conventional activated sludge, was accordingly 
reported for, e.g., estrogens (Joss et al., 2004, 2006b) and few anti-
inflammatory pharmaceuticals (Joss et al., 2006b; Bernhard et al., 2006; 
Radjenovic et al., 2009). Negligible differences between MBRs and conven-
tional activated sludge systems were frequently observed (Clara et al., 2005; 
Joss et al., 2005; Bernhard et al., 2006; Abegglen et al., 2009; Sui et al., 
2011). More recently, biotransformation in MBBRs under aerobic conditions 
was found to occur at higher rates than in activated sludge for a number of 
pharmaceuticals (Falås et al., 2012, 2013), though not being confirmed for all 
tested XTCs. 
To date, evidences on the influence of SRT on biotransformation could not be 
generalized for all XTCs investigated, leading to the conclusion that the im-
pact of such operational parameter may be chemical-specific. In this PhD the-
sis, we aimed at increasing the understanding in this matter by assessing the 
biological transformation of a number of XTCs in pre-denitrifying MBBRs 
(Paper II). Furthermore, we proposed and successfully tested a methodology 
to assess the impact of SRT in the full-scale removal of XTCs by comparing 
model predictions and literature data (Paper III).   
2.2.2 Sorption/desorption 
Partitioning of XTCs to solid matrices in wastewater (e.g., suspended solids, 
suspended or attached biomass) is a physico-chemical process involving two 
reverse mechanisms, i.e. sorption from aqueous to solid phase and desorption 
from solid to aqueous phase (Joss et al., 2006b). As an equilibrium process, 
solid-liquid partitioning is considered completed when the rate of sorption 
equals the rate of desorption, i.e. there is not net change in the XTC concen-
trations in solid and aqueous phase. For each XTC at equilibrium, the ratio 
between these two concentrations is fixed, and the extent of sorption can be 
described by the solid-liquid partition coefficient Kd (L gTSS-1; Eq. 2.1): 
)( ,,,, TSSeqLIeqSLeqLIeqSLd XCCCXK                (2.1) 
where XSL,eq (µg gTSS-1) and CSL,eq (µg L-1) denote the concentration in solid 
phase at equilibrium per gram sorbent and per litre of bulk solution, respec-
tively, CLI (µg L-1) the aqueous concentration. XTSS (gTSS L-1) is most fre-
quently used to indicate the concentration of sorbent in solution. Eq. 1 repre-
sents a simplified (linear) case of the empirical Freundlich equation (Freun-
dlich, 1909; Eq. 2.2): 
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 neqLIfTSSeqSLeqSL CKXCX ,,,                  (2.2) 
where Kf denotes the Freundlich coefficient (µg1-n Ln g-1) and n the linearity 
parameter (-). This equation allows accounting for saturation (n<1) or syner-
gistic (n>1) partitioning effects at high XTC concentrations. Partitioning can 
be considered as an affinity process between two organic phase (XTCs and 
organic matter in solids), and can be further described the by the partition 
coefficient normalized to organic carbon, Koc (Karickhoff et al., 1979; Eq. 
2.3): 
ocdoc fKK                         (2.3) 
where foc denotes the organic carbon fraction in the sorbent (e.g., gOC gTSS-
1).  
Sorption/desorption equilibrium is assumed to be reached instantaneously, 
defining partitioning as a non-rate-limiting process during wastewater treat-
ment. Experimental observations confirmed this assumption, showing that 
equilibrium can be reached within 0.5–1 h (Ternes et al., 2004a; Andersen et 
al., 2005; Yi and Harper, 2007; Khunjar and Love, 2011; Plósz et al., 2013). 
Particulate matter represents a rather heterogeneous sorbent for XTCs in 
wastewater. Partitioning can in fact occur—to different extents—onto hydro-
lysable organic matter, colloidal organic carbon, exopolymeric substances 
(EPSs) and cell surfaces (Siegrist et al., 2003; Holbrook et al., 2004; Barret et 
al., 2010a,b; Khunjar and Love, 2011; Delgadillo-Mirquez et al., 2011). In 
addition, sorption onto dissolved organic matter was found significant for 
hydrophobic chemicals (e.g., PAHs) (Barret et al., 2010a,b; Delgadillo-
Mirquez et al., 2011). In wastewater systems, XTCs undergo solid-liquid par-
titioning in raw sewage, reaching equilibrium during in-sewer transport, and 
during secondary treatment, onto suspended or attached biomass (Ternes et 
al., 2004b; Senta et al., 2013; Petrie et al., 2015). Removal of sorbed XTCs 
from sewage mostly occurs in primary settlers, via sedimentation of raw in-
fluent solids as primary sludge, and secondary settlers, with sedimentation 
and subsequent wastage of (a fraction of) activated sludge. The relative im-
portance of these two processes may be substantially different, due to prima-
ry and secondary sludge composition and physico-chemical characteristics 
(Ternes et al., 2004b).  
Traditionally, partitioning has been associated to hydrophobicity of chemi-
cals, and Koc predictions based on Kow (octanol-water partition coefficient of 
the neutral species) or D (pH-dependent distribution coefficient) have been 
14 
established (e.g., Sablijc et al., 1995). This approach was proved insufficient 
in predicting XTC sorption onto activated sludge (Ternes et al., 2004a; Hörs-
ing et al., 2011; Stevens-Garmon et al., 2011; Hyland et al., 2012; Sathy-
amoorthy and Ramsburg, 2013). Other major partitioning mechanisms have 
been accordingly identified (MacKay and Vasudevan, 2012), namely electro-
static interactions (e.g., Coulombic attraction or cation exchange) and surface 
complexation. In wastewater systems, pH and ionic strength of the aqueous 
solution can thus influence sorption by (i) changing the surface chemistry of 
the sorbent (Wang et al., 2000); and (ii) most importantly, changing the activ-
ity of the ionizable sorbate or leading to the formation of complexes (Trapp et 
al., 2010; MacKay and Vasudevan, 2012). Where detailed evidences on the 
effect of pH on the partitioning of ionizable XTCs have been obtained for soil 
matrices (Franco and Trapp, 2008; Franco et al., 2009; see 2.2.4), little in-
formation is available for sorbents in wastewater systems (e.g., sludge matri-
ces). In this PhD thesis, we aimed at providing insights on the influence of 
pH and ionic strength on the partitioning of an ionizable antibiotic (the zwit-
terionic ciprofloxacin) onto activated sludge (Paper I). 
Chemicals can be entrapped to remote regions of the solid matrix, a process 
also known as sequestration or slow sorption. Sequestered amounts cannot be 
considered in equilibrium with the aqueous phase, thus being potentially not 
bioavailable (Schwarzenbach et al., 2003). The significance of sequestration 
was earlier shown in soils and sediments (Pignatello and Xing, 1996; Alex-
ander, 2000). Experimental (Kim et al., 2005; Yi and Harper, 2007a; Wu et 
al., 2009) and model-based (Plósz et al., 2012) observations in sewage sludge 
showed that XTC sequestration may also be relevant to wastewater systems. 
Sorbed XTCs may thus include a sequestered fraction undergoing extremely 
slow or no desorption (thus exhibiting ‘sorption hysteresis’; Yi and Harper, 
2007a). 
2.2.3 Retransformation 
The increase of aqueous concentrations, corresponding to the formation of 
parent pharmaceuticals, has been observed during laboratory-scale experi-
ments and in full-scale WWTPs (resulting in ‘negative’ removal efficiencies; 
Stadler et al., 2012). Different processes may be responsible for such obser-
vations, and have been thus grouped under the general term ‘retransfor-
mation’. The influence of retransformation on the full-scale elimination of the 
antibiotic sulfamethoxazole was assessed in Paper III. Here we present a 
detailed assessment of the main observed retransformation mechanisms (also 
summarized in Fig. 2.2). 
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Figure 2.2. Summary of the main mechanisms leading to the formation of parent XTCs in 
aqueous phase—indicated by the orange circle (adapted from Plósz et al., 2013b). XTCs in 
parentheses refer to chemicals, for which each different mechanism was observed and/or 
hypothesized. A detailed description of the different mechanisms is provided in the para-
graphs below. 
 
Metabolite deconjugation  
Following administration, XTCs are metabolized via: (i) functionalization 
reactions (e.g., oxidation, hydroxylation, reduction, mostly catalysed by 
CYP450 enzymes); and (ii) conjugation reactions (e.g., glucuronidation, sul-
fation, acetylation) to facilitate the urinary excretion of metabolites (Zhang et 
al., 2008). These processes have been observed in humans, animals (Graf-
ström et al., 1979) and plants (Komossa et al., 1995). Formerly known as 
Phase I and Phase II reactions, respectively, these two types of processes can 
occur independently of each other, resulting e.g., in the direct conjugation of 
parent XTCs (Gruengerich, 2008; Testa et al., 2012). Parent XTCs and me-
tabolites are eventually excreted with urine (the largest fraction) and 
bile/faeces. Excreted conjugates of the parent XTCs (approximately 22% of 
first-step human metabolites; Testa et al., 2012) may retransformation back to 
the parent form following cleavage of the conjugated moiety—also known as 
deconjugation. In wastewater and water systems, biological deconjugation 
was hypothesized or observed for several XTCs: (i) natural and synthetic 
estrogens (Ternes et al., 1999; Andersen et al., 2003; Joss et al., 2004; Gomes 
et al., 2009); (ii) carbamazepine (Ternes, 1998; Joss et al., 2005; Vieno et al., 
2007; Plósz et al., 2012; Bahlmann et al., 2014) and its functionalized meta-
bolites (Miao et al., 2005; Bahlmann et al., 2014; Gurke et al., 2015); (iii) 
d. Release from particulate matter (hydrolysis of 
particulates, release from faecal matter) 
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diclofenac (Lee et al., 2012; Plósz et al., 2012; Vieno and Sillanpää, 2014); 
(iv) sulfonamide antibiotics (Göbel et al., 2005, 2007; Joss et al., 2006a; 
Radke et al., 2009; Plósz et al., 2010a; García-Galán et al., 2012a; Falås et 
al., 2013; Senta et al., 2013; Stadler et al., 2015); (v) ibuprofen (de Graaff et 
al., 2011). Microbial deconjugation is typically a fast process (Joss et al., 
2006), resulting in the almost complete elimination of conjugates in full-scale 
WWTP (Göbel et al., 2005, 2007; Stadler et al., 2015). Nevertheless, relative 
persistence of certain conjugates (e.g., N-glucuronides) has been hypothe-
sized (Bahlmann et al., 2014). Although the significance of deconjugation 
during wastewater treatment has been acknowledged, detailed empirical evi-
dences are still scarce—being limited to estrogens—mainly due to analytical 
challenges (García-Galán et al., 2008; Celiz et al., 2009; Griffith et al., 2014; 
Brown and Wong, 2015). 
Abiotic formation 
Few examples of abiotic retransformation of parent XTCs have been report-
ed. Tetracycline antibiotics are excreted in unchanged and epimerized form 
(Sengeløv et al., 2003; Agwuh and MacGowan, 2006). In aqueous media, un-
changed tetracyclines can be further epimerized (McCormick et al., 1957; 
Remmers et al., 1963). Reverse epimerization—with formation of unchanged 
tetracycline—was observed in activated sludge and soil under neutral to alka-
line conditions and in the presence of divalent cations (Halling-Sørensen et 
al., 2002). 
Formation from other XTCs 
Parent XTCs and/or metabolites can be the transformation products of other 
XTCs during biological wastewater treatment. The most known example is 
the formation of the estrogen E1 (estrone) from E2 (17β-estradiol) observed 
(Ternes et al., 1999; Joss et al., 2004; Urase and Kikuta, 2005) and modelled 
(Joss et al., 2004; Urase and Kikuta, 2005) in activated sludge. The reverse 
process was observed under anaerobic conditions (Joss et al., 2004). Analo-
gous processes include the formation of (i) atenolol acid (a metabolite of 
metoprolol) from atenolol in activated sludge (Radjenovic et al., 2008); (ii) 
ciprofloxacin from fungal degradation of enrofloxacin (Wetzstein et al., 
2006). Notably, commercial XTCs can be formed from the human metabo-
lism of other substances (e.g., diazepam metabolized to oxazepam; Kovalova 
et al., 2012), thus generating additional emissions to WWTPs without being 
directly consumed. 
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Release from particulate matter 
Formation of XTCs in aqueous phase had been eventually attributed to the 
release of amounts present in solid phase via a number of hypothesized 
mechanisms: (i) release from faecal matter e.g., of macrolides (Göbel et al., 
2007), justifying aqueous concentration increases from WWTP influent to 
effluent (Terzic et al., 2008; Gao et al., 2012; Oertel et al., 2014); (ii) biotic 
exocellular hydrolysis of particulate, colloidal and dissolved organic matter 
(Larsen and Harremoës, 1994; Guellil et al., 2001), on which XTCs are 
sorbed (Holbrook et al., 2004; Barret et al., 2010a,b; Delgadillo-Mirquez et 
al., 2011); and (iii) desorption due to changes in wastewater conditions (e.g., 
pH).  
2.2.4 Ionization 
A significant fraction of marketed XTCs is ionizable (Manallack, 2009; Fran-
co et al., 2010) and can be present in neutral and/or ionized form at environ-
mental pH conditions. Ionization is as an instantaneous process in aqueous 
solution and fractions of neutral and ionized species (anionic, cationic, zwit-
terionic) at equilibrium are expressed as a function of pH and ionization con-
stants (pKa) using Henderson-Hasselbach equations. For monovalent ionics 
(acids: α = 1; bases: α = -1), ionic fractions are calculated according to (Eq. 
2.4–2.5): 
 )(101/1 apKpHn                       (2.4) 
ni  1                         (2.5) 
where the subscripts ‘n‘ and ‘i‘ denote neutral and ionic (anionic or cationic) 
species, respectively. XTCs in relevant categories (e.g., fluoroquinolone and 
tetracycline antibiotics) are zwitterionic and undergo internal proton migra-
tion, with coexistence of two oppositely charged groups in an overall neutral 
molecule. The latter speciation coexists with the truly neutral (uncharged) 
configuration, without internal proton migration (Pagliara et al., 1997). Zwit-
terionic XTCs can thus speciate as anions (-), cations (+), zwitterions (±) and 
in uncharged form (0), and the respective fractions are determined from (Eq. 
2.6–2.10): 
 )()( 1,2, 10101/1 pHpKpKpHn aa                  (2.6) 
 )( 1,10 pHpKn a                        (2.7) 
 )( 2,10 apKpHn                        (2.8) 
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0  n                        (2.9) 
0
ZK                         (2.10) 
where pKa,1 and pKa,2 denote the acidic and the basic ionization constant, re-
spectively. The ratio between zwitterionic and uncharged fraction (which 
combined represent the neutral configuration) is known as constant of tauto-
meric equilibrium KZ (Eq. 2.10; Pagliara et al., 1997). 
Ionization of XTCs has implications on other physico-chemical and biologi-
cal fate processes. When occurring via non-hydrophobicity-related mecha-
nisms (2.2.2), solid-liquid partitioning is influenced by the charge of sorbent 
and sorbate (Trapp et al., 2010). Sorbents (soil, activated sludge) typically 
exhibit negatively charged surfaces (organic acidic groups, clay minerals) at 
environmental pH (e.g., Wang et al., 2000; Delle Site, 2001; MacKay and 
Vasudevan, 2012), determining e.g., limited sorption potential of anionic 
species due to repulsion effects (Carrasquillo et al., 2008; Franco et al., 2009; 
Tülp et al., 2009; Vasudevan et al., 2009). Furthermore, uptake of XTCs in 
cells is significantly slower for ionized than for neutral species, influencing 
XTC accumulation in plants (Trapp, 2004), bioaccumulation and toxicity in 
algae and fish (Rendal et al., 2011) and biotransformation in activated sludge 
systems (Gulde et al., 2014). Overall, the extent of the impact by XTC ioniza-
tion is determined by the pH conditions, at which these processes occur.  
2.2.5 Other processes 
A number of other processes have been traditionally considered for the re-
moval of organic xenobiotics in wastewater treatment systems (see, e.g., 
Vezzaro et al., 2014), including (i) volatilization and stripping; (ii) photoly-
sis; and (iii) chemical hydrolysis. These processes may be of limited signifi-
cance for the removal of XTCs assessed in this PhD thesis. Elimination from 
the aqueous phase via volatilization and/or stripping (induced, e.g., by aera-
tion in activated sludge reactors) is considered negligible, as expected by the 
extremely low volatility of XTCs (dimensionless air-water partition coeffi-
cient Kaw < 4·10-6; Trapp and Harland, 1995) High turbidity of raw sewage 
and mixed sludge liquor is likely to hinder photolysis of XTCs in convention-
al WWTPs (Michael et al., 2013). Chemical hydrolysis of pharmaceuticals 
was also shown negligible in activated sludge (Li and Zhang, 2010). Never-
theless, this process was shown to be responsible for the removal of illicit 
drugs in raw sewage (Senta et al., 2014; Ramin et al., in preparation). Simul-
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taneous evaluation of the listed processes in laboratory-scale abiotic degrada-
tion experiments (Helbling et al., 2010; Gulde et al., 2014) showed their 
overall limited relevance for the elimination of tested pharmaceuticals. 
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3 Modelling the fate of XTCs during (and 
beyond) wastewater treatment 
Wastewater treatment systems receive emissions of a wide range of synthetic 
organic chemicals, motivating a three-decade tradition of fate models. Early 
attempts focused, among others, on the fate of down-the-drain chemicals in 
consumer products (e.g., surfactants; Siegrist et al., 1989). Recent attention 
has been addressed to pharmaceuticals and biocides (XTCs) as a result of 
their widespread consumption and of the acknowledged environmental risks 
associated to them. 
In agreement with the former regulation on the risk assessment of pharmaceu-
ticals (EMEA, 2006), simplified approaches have been often adopted in re-
gional fate studies. Removal efficiency in WWTPs has been in fact neglected 
(Stuer-Lauridsen et al., 2000; Besse and Garric, 2008) or considered as a 
fixed (Grung et al., 2009; Morasch et al., 2010) or variable (Johnson and Wil-
liams, 2004; Ort et al., 2009; Johnson et al., 2013) sink term based on full-
scale measurements.  
Research in the field of XTC fate modelling generally faced two major chal-
lenges: (i) understand the mechanisms of XTC elimination during (biological) 
wastewater treatment; (ii) provide for reliable predictions (for, e.g., risk as-
sessment studies) with limited data requirement. Accordingly, models devel-
oped and tested for XTC fate prediction can be distinguished in two major 
categories: multimedia (fugacity and activity) models and concentration-
based models. Multimedia models require limited input and are typically used 
in generic fate and exposure assessments (Keller, 2006). Conversely, concen-
tration-based models were used for fate predictions in selected laboratory- 
and/or full-scale systems (also at catchment level), often implemented as ex-
tension of Activated Sludge Models (ASMs; Henze et al., 2000) and. In both 
cases, modelling exercises have primarily focused on the elimination during 
primary and secondary wastewater treatment. Eventually, the use of either 
model types aimed at predicting (i) XTC removal efficiencies and fractions of 
XTC influent load removed via relevant processes (e.g., partitioning); and (ii) 
XTC concentrations at different stages (i.e., primary or final effluent) and in 
different compartments (wastewater, sludge) of wastewater treatment.   
Relevant examples of these two types of model have been assessed and com-
pared (Table 3.1) according to different criteria: (i) conditions assessed 
(steady-state or dynamic); (ii) fate processes included; (iii) scale of applica-
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tion (laboratory, pilot and/or full scale); and (iv) XTC categories investigat-
ed. A brief presentation of the history and the main features of multimedia 
and concentration-based models is given in the following paragraphs. 
3.1 Multimedia fugacity and activity models 
3.1.1 Fugacity-based models 
Multimedia models are generally defined as mathematical tools used for fate 
predictions of organic chemicals in systems subdivided in a number of dis-
tinct well-mixed compartments (or ‘media’) (Trapp and Matthies, 1998). Ear-
ly examples of multimedia models (“Mackay models”) were established to 
predict the distribution of organic contaminants in different media (air, water, 
soil, sediments) of an ideal environment section (the ‘Unit World’; Mackay, 
1979), under steady state conditions. Mackay models—and most of multime-
dia models in general—use fugacity as state variable to predict concentra-
tions in environmental media. Fugacity (f; Lewis, 1901) is a thermodynamic 
property (partial pressure, Pa) describing the tendency for a chemical of es-
caping a certain phase. In analogy with thermodynamics, at equilibrium the 
fugacity in different compartments is equal (Mackay, 1979). Concentrations 
in different compartments are linearly correlated to the respective fugacities 
(Eq. 3.1): 
fZC                           (3.1) 
where Z (mol m-3 Pa-1) is defined as the fugacity capacity. Z quantifies the 
extent of partitioning to a different compartments, and can be calculated from 
typical distribution coefficients (e.g., from Kd for solids) (Mackay and Pater-
son, 1981).  
Mackay and Paterson (1981, 1982) defined different modelling levels, de-
pending on the conditions (steady-state or dynamic; equilibrium or non-
equilibrium between compartments), on the type of systems assessed (open or 
closed) and on the occurrence of reactions (degradation) within media. To 
date, Mackay models have been applied and tested until level III (steady-
state, open system, non-equilibrium, degradation), thus describing only sys-
tems in steady-state conditions. In case of non-equilibrium, chemical transfer 
processes (advection, partitioning) occur between compartments. Transfer 
rates are described using a first-order equation with respect to f (Eq. 3.2): 
Dfdtdm /                        (3.2) 
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where m is the mass of chemical (mol) and D (mol h-1) is the transport coeffi-
cient (Mackay and Paterson, 1982). By calculating mass balances within each 
compartment (Eq. 3.2), fugacities (and thus concentrations, Eq. 3.1) in differ-
ent compartments can be determined.  
Multimedia models based on the fugacity approach have been considered for 
fate modelling in WWTPs. The most prominent example in this category is 
SimpleTreat, originally developed by Struijs et al. (1991) and progressively 
updated and revisited until v. 4.0 (Struijs, 2014; Fig. 3.1). SimpleTreat is a 
level III Mackay model simulating an ideal WWTP (10,000 PE) with primary 
settling (optional), aerated activated sludge reactor and secondary settler. 
Each reactor is subdivided in different media (air, water, suspended solids, 
sludge—‘9 boxes’) not in equilibrium with each other. Besides the raw sew-
age input to the WWTP (with XTC present both in water and suspended sol-
ids), processes simulated in the system include: (i) advection between differ-
ent reactors; (ii) diffusion (i.e. partitioning) between different media (e.g., 
volatilization, sorption); and (iii) XTC biodegradation in aqueous phase or in 
aqueous and solid phase (depending on modeller’s choice). SimpleTreat can 
predict the fractions of influent XTC load removed via different pathways 
(volatilization, sorption onto primary or secondary sludge, biodegradation) as 
well as XTC concentrations in sludge and final effluent. 
Other examples of fugacity WWTP models include STP (Clark et al., 1995) 
and STP-EX (Seth et al., 2008). A simplified approach is used, assuming that 
media in each treatment stage are in equilibrium and thus reducing the num-
ber of state variables in the model (Table 3.1). SimpleTreat and STP were 
used to evaluate removal in alternative WWTP configurations to the default 
one, e.g. in activated sludge with intermittent operation (Fauser et al., 2003) 
or in aerated lagoons (Seth et al., 2008).  
An important assumption of traditional multimedia fugacity models (Sim-
pleTreat v. 3.1, STP, STP-EX) was that ionized species do not partition from 
water phase to adjacent media. Partition coefficients to organic carbon (Koc) 
are accordingly predicted using Kow-based regressions for non-polar hydro-
phobic organic chemicals (Sablijc et al., 1995). This assumption was shown 
to be rather unrealistic for solid-liquid partitioning. The necessity of account-
ing for partitioning of ionized species has been recently demonstrated, and 
alternative regressions were accordingly developed to predict Koc of ionizable 
chemicals (Franco and Trapp, 2008; Franco et al., 2009, 2013a). More recent 
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SimpleTreat versions (3.2: Franco et al., 2013a,b; 4.0: Struijs, 2014) have 
been updated to include these regressions. 
3.1.2 Activity-based models 
An alternative approach to model the fate of ionizable XTCs in multimedia 
systems has been proposed by Trapp et al. (2010). In this approach, fugacity 
is replaced by the activity concept (Lewis, 1907). Activity at (mol m-3) de-
scribes the apparent concentration of a chemical in non-ideal solutions, con-
sidering e.g. ionic strength effects (Franco and Trapp, 2010). In analogy with 
fugacity, the concentration in a compartment is linearly correlated to the 
chemical activity at (Eq. 3.3) 
BaC t                         (3.3) 
where B is defined as the bulk activity capacity (–) analogous to the coeffi-
cient Z (Eq. 3.1). The novelty of this approach relies in the possibility of sep-
arately accounting for the activity of neutral (an) and ionized species (ai), 
where the total activity at is equivalent to (Eq. 3.4): 

i
int aaa                       (3.4) 
Neutral and ionic activities can be further determined from the respective ion-
ic fractions ϕn and ϕi (Eqs. 3.5, 3.6): 
ntn aa                          (3.5) 
iti aa                          (3.6) 
where ϕn and ϕi can eventually be calculated using Henderson-Hasselbach 
equations. Intermedia transport rates (advection, partitioning) under non-
equilibrium conditions and degradation rates are be described by a first-order 
law (Eq. 3.7): 
tTadtdm /                        (3.7) 
where T (m3 h-1) is defined in analogy with the transport coefficient D for 
fugacity.  
The first application of the activity approach was the regional model (MA-
MI–Multimedia Activity Model for Ionics; Franco and Trapp, 2010). Recent-
ly, activity has been used to replace fugacity as state variable in the multime-
dia WWTP model Activity SimpleTreat (Franco et al., 2011). This model was 
developed as a revisited version of SimpleTreat 3.1, maintaining its major 
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features (e.g., WWTP size and structure; Fig. 3.1) but aiming at improving 
fate predictions of ionizable XTCs. Activity SimpleTreat accordingly in-
cludes updated Koc regressions for ionizable organic chemicals (Franco et al., 
2009). In this PhD thesis (Paper IV), Activity SimpleTreat was applied for 
the first time for fate prediction of ionizable XTCs in WWTPs. 
Overall, multimedia fate models based on either fugacity or activity concepts 
were developed as generic tools for exposure assessment under steady-state 
conditions. The use of multimedia models thus aims at predicting, in an ideal 
conventional WWTP, steady-state XTC elimination and concentrations (ef-
fluent, sludge) to further estimate exposure levels in environmental recipients 
(freshwater, soil). Predictions are meant to be obtained using limited input 
data, i.e. (i) steady-state XTC emissions to WWTPs from e.g., regional or 
catchment consumption data; and (ii) properties of the chemical investigated 
(molecular weight, vapour pressure or Henry’s law constant, solubility, dis-
sociation constants, octanol-water partition coefficient and biodegradation 
rate in activated sludge).  
All these features made multimedia models suitable for use in decision sup-
port tools frameworks. Specifically, SimpleTreat 3.1 is currently part of the 
European Union System for Evaluation of Substances (EUSES; EC, 2004), 
used for environmental risk assessment of XTCs according to the REACH 
regulation. Notably, the predictive capacity of multimedia models has been 
often tested in terms of removal efficiency with measurements in pilot- and 
full-scale WWTPs (Table 3.1). On the contrary, few attempts of predicting 
XTC concentrations using real emission data exist (Artola-Garicano et al., 
2003b; Cunningham et al., 2012). In Paper IV, we aimed at filling this 
knowledge gap by testing Activity SimpleTreat and predicting concentrations 
(in sewage sludge and effluent) using real emission data from different geo-
graphical regions of the EU. 
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Figure 3.1. Layout of the ideal WWTP described in SimpleTreat and Activity SimpleTreat 
(adapted from EChA, 2008).  
 
3.2 Concentration-based models 
Concentration-based models refer to rather broad category of models, em-
ploying concentration as state variable to describe the fate of XTCs during 
wastewater treatment. Similarly to multimedia models, XTC concentrations 
are defined in aqueous, sorbed and (when relevant) gaseous phase. Models 
selected (Table 3.1) are characterized by varying levels of model complexity 
and data requirement, which will be considered for model description in this 
section. The heterogeneity of concentration-based models is further high-
lighted by the number of different notations used to describe the same state 
variable, e.g., aqueous concentration (SNTA, S, C, CW, CW,bulk, Cf, Cfree, SXOC, 
Cdissolved, CLI, SPhAC, SMP) and  sorbed concentration (XNTA, q, X, CS, COC, XXOC, 
CSL, cP, cDCM, C*, XMP). 
In steady-state concentration-based models, analytical solutions, derived from 
mass balance equations, are used to predict XTC concentrations and removal 
efficiencies. Although model application in laboratory-scale studies was test-
ed (Birch, 1991; Suarez et al., 2010), steady-state models have been mainly 
associated to full-scale fate predictions. Steady-state generic WWTP models 
have been developed and applied for: (i) scenario simulations in an ideal 
WWTP (Byrns, 2001); (ii) model validation with measured data, following 
model implementation of actual design parameters from the WWTPs investi-
gated (Namkung and Rittmann, 1987; WW-TREAT by Cowan et al., 1993). 
In both cases, limited data was required in terms of model input (chemical 
properties, retrieved from literature or estimated via targeted experiments) 
and of full-scale measurements (assuming steady-state WWTP operation). 
Steady-state full-scale concentration-based models thus exhibit significant 
similarities to multimedia WWTP models.    
Primary settler Aeration tank
Secondary 
settler
Air
Water
Suspended solids
Sludge
Advective flow
Diffusive flow
Biodegradation
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Dynamic concentration-based models are sets of ordinary differential equa-
tions, describing specific process rates (included in a Gujer-Petersen matrix) 
and overall mass balances in the systems studied. Dynamic fate models were 
often developed as extension of ASMs (see Table 3.1), thus providing a sim-
ultaneous description of conventional pollutant and XTC removal processes 
during wastewater treatment. 
To gain process understanding under controlled conditions, dynamic models 
were used for fate predictions in laboratory-scale systems. Models were cali-
brated to data obtained in batch (e.g., Artola-Garicano et al., 2003a; Urase 
and Kikuta, 2005) or continuous flow experiments (e.g., Fernandez-Fontaina 
et al., 2014). Estimated parameter values were used to compare chemicals, 
operational conditions tested and to derive implications for removal in full-
scale WWTPs (e.g., Joss et al., 2006a).  
Dynamic models were also applied for fate predictions in selected pilot- and 
full-scale WWTPs, mostly focusing on secondary treatment. The application 
of dynamic models aimed at in-depth assessing XTC fate considering that: (i) 
operation in WWTPs is dynamic; and (ii) most importantly, influent loadings 
of XTCs originating from household and industrial releases exhibit signifi-
cant short-term (Melcer et al., 1994; Joss et al., 2005; Ort and Gujer, 2006; 
Ort et al., 2010a; Plósz et al., 2010b) and long-term (e.g., seasonal; Coutu et 
al., 2013; Marx et al., 2015) variations. Dynamic models developed, e.g., by 
Melcer et al. (1994; TOXCHEM) and Lindblom et al. (2009) were calibrated 
to continuous pilot-scale monitoring data. Furthermore, comprehensive dy-
namic modelling exercises (e.g., ASM-X; Plósz et al., 2010a, 2012) com-
bined (i) parameter estimation with results from targeted (batch) experiments; 
and (ii) model validation with full-scale monitoring data. Clearly, refined 
predictions obtained with dynamic models required more experimental data 
than for steady-state and multimedia models.  
More recently, full-scale dynamic models have been employed in integrated 
dynamic modelling tools (Lindblom et al., 2006; Vezzaro et al., 2014; Snip et 
al., 2014), simulating XTC fate at catchment scale and describing fate and 
transport in sewer systems, WWTPs and recipients. Generic WWTP layouts 
were considered using, e.g., Benchmark Simulation Model No. 1 (e.g., 
BSM1; Alex et al., 2008). To date, application of integrated models in 
WWTP catchments has been limited to realistic scenario simulations.  
Several dynamic models explicitly described the influence of redox condi-
tions on the fate of XTCs in wastewater systems (Joss et al., 2004; Wick et 
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al., 2009; Xue et al., 2010; Plósz et al., 2010a, 2012), differently from multi-
media models and most of steady-state models. Furthermore, elimination un-
der aerobic nitrifying conditions was specifically assessed to explore the pos-
sibility of cometabolic XTC biotransformation by nitrifying bacteria (Wick et 
al., 2009; Plósz et al., 2012; Sathyamoorthy et al., 2013; Fernandez-Fontaina 
et al., 2014). 
The Activated Sludge Modelling framework for Xenobiotics (ASM-X) is a 
relevant example of dynamic concentration-based model. ASM-X was devel-
oped as an extension of ASM1 (Henze et al., 1987) and successfully calibrat-
ed and used for fate prediction of pharmaceuticals (antibiotics: Plósz et al., 
2010a; diclofenac and carbamazepine; Plósz et al., 2012) in the Bekkelaget 
full-scale WWTP (Oslo, Norway). ASM-X predictions were based on prelim-
inary model identification and calibration using batch experimental data and 
validation with full-scale concentration data from continuous monitoring 
ASM-X was further implemented in integrated catchment models (Snip et al., 
2014) and to specifically assess fate of illicit drugs in upstream sewer sys-
tems (Plósz et al., 2013a). State variables are represented by the concentra-
tions of the aqueous parent XTC fraction (CLI), of the sorbed parent fraction 
(CSL) and of the retransformable fraction (CCJ), identifying a range of chemi-
cals forms capable of undergoing retransformation to CLI (see 2.2.3). Fate 
processes are separately described for different redox conditions and included 
biological transformation of CLI, retransformation of CCJ back to CLI fraction 
and sorption/desorption onto and from activated sludge. Process rates are de-
scribed using pseudo-first-order (biotransformation, retransformation, sorp-
tion) or first-order rate equation (desorption) with respect to XTC concentra-
tions. Relevant parameters thus include the biotransformation rate constant 
kbio (L gTSS-1 d-1), the retransformation rate constant kdec (L gTSS-1 d-1), the 
solid-liquid partition coefficient Kd (L gTSS-1) and the desorption rate kdes (d-
1). 
In this PhD thesis, we evaluated the extension of the ASM-X framework to 
describe sorption of ionizable XTCs (Paper I) and its application to charac-
terize XTC biotransformation in laboratory-scale MBBRs (Paper II). Fur-
thermore, full-scale ASM-X predictions were compared to literature removal 
efficiency data and used to assess the impact of retransformation in XTC 
elimination (Paper III). 
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3.3 Modelling fate processes: biotransformation 
Among the multimedia and concentration-based models reviewed (Table 3.1), 
agreement can be found on the approaches used to simulate fate processes. 
Specifically, (i) solid-liquid partitioning is described using Kd-based linear 
model (Eq. 2.1);  (ii) volatilization and stripping are not relevant mechanisms 
when considering pharmaceuticals and biocides (XTCs assessed in this PhD 
thesis); and (iii) retransformation processes should be considered when XTCs 
are present in conjugated form and/or parent XTCs can be formed from other 
XTCs (see, e.g., natural estrogens). On the contrary, several different ap-
proaches have been tested when modelling XTC biotransfor-
mation/biodegradation during wastewater treatment.  
The first discrepancy is represented the phase, in which biotransformation is 
assumed to take place. Most of the models reviewed described biotransfor-
mation of XTCs rigorously in aqueous phase, considering the aqueous con-
centration as the only biologically available (Alexander, 2000; Schwarzen-
bach et al., 2003). The aqueous fraction can include both the freely dissolved 
fraction and the fraction sorbed onto dissolved and colloidal matter (Delga-
dillo-Mirquez et al., 2011). Alternative approaches have been explicitly ad-
dressed in Table 3.1 (see ‘Notes’) and include: (i) biotransformation of only 
the sorbed concentration (e.g., the ‘two-phase model’ by Urase and Kikuta, 
2005); and (ii) biotransformation of both aqueous and sorbed concentrations 
(e.g., WW-TREAT by Cowan et al., 1993). In both cases, sorption is consid-
ered as an initial mechanism making XTCs available for biological transfor-
mation (bio-sorption approach). This hypothesis was considered to describe 
sorption and transformation in sludge EPS (Khunjar and Love, 2011), howev-
er major evidences for bacterial cells are lacking. Nevertheless, a few de-
tailed literature studies considered the hypothesis as unlikely (e.g., Delgadil-
lo-Mirquez et al., 2011). Notably, in SimpleTreat and Activity SimpleTreat 
modellers can select whether biotransformation takes place in aqueous phase 
or both in aqueous and sorbed phase.  
The major difference among all models reviewed is certainly the mathemati-
cal description of the rate of biotransformation/biodegradation. In the follow-
ing paragraphs, we will focus on models describing the biotransformation of 
only aqueous XTC concentration (C, µg L-1). The term X will generically in-
dicate the concentration of biomass in terms of TSS (gTSS L-1; e.g., Joss et 
al., 2006a,b), VSS (gVSS L-1; e.g., Fernandez-Fontaina et al., 2014) or active 
heterotrophic or autotrophic biomass (gCOD L-1; e.g., Majewsky et al., 
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2011a; Sathyamoorthy et al., 2013). A common assumption used in all mod-
els, describing biotransformation in suspended growth systems, is that uptake 
or diffusion into cells is not a rate limiting process, and XTC concentrations 
in cells equals the concentration in bulk aqueous phase (Schwarzenbach et 
al., 2003).  
Monod-based kinetic expressions with respect to XTC concentration were 
considered to describe biotransformation as a growth process for a population 
of specialist degraders XC (Eq. 3.8; Siegrist et al., 1989; Lindblom et al., 
2006, 2009): 
C
CC
C X
KC
C
Ydt
dC
)(
max,


                  (3.8) 
where µC,max, YC and KC denote the maximum growth rate (d-1), the yield co-
efficient (gXC gC-1) and the affinity constant (mgC L-1) for growth on XTCs. 
Acknowledging that XTCs are secondary susbtrates, present in concentrations 
significantly lower than their affinity constant, and that their biotransfor-
mation can be catalysed by non-specific enzymes widely present in the mi-
crobial population X (Alexander, 1985; Namkung and Rittmann, 1987; Ny-
holm et al., 1996; Alvarez-Cohen and Speitel, 2003; Schwarzenbach et al., 
2003), several models (e.g., Joss et al., 2006a,b; Wick et al., 2009) included a 
pseudo-first-order rate equation (Eq. 3.9) for biotransformation:  
CXk
dt
dC
bio                       (3.9) 
where kbio is defined as the biotransformation rate constant (L gX-1 d-1). Eq. 
3.9 represents a simplification of the generic Monod equation at low concen-
trations (C<<KC). The attribute ‘pseudo’ refers to the dependency from the 
term X, assumed constant when considering negligible biomass growth during 
the investigation (Joss et al., 2006a). When used as extension of models (e.g., 
ASMs) describing growth processes, Eq. 3.9 can be defined as a second-order 
rate equation, effectively describing cometabolic XTC transformation (Liu et 
al., 2014). In order to account for the instantaneous adjustment of partitioning 
equilibria via desorption during biotransformation, Eq. 3.9 can be rewritten 
(Joss et al., 2006a): 
CX
XK
k
dt
dC
d
bio
)1(                      (3.10) 
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We note that Eq. 3.10 is a compact version of a partitioning-
biotransformation model, employing Eq. 3.9 and separate process equations 
for sorption and desorption.  
Using the assumption of negligible biomass growth (constant X) during batch 
experiments or continuous operation, a first-order biotransformation rate was 
also used (Eq. 3.11; Struijs et al., 1991; Artola-Garicano et al., 2003a; Vezza-
ro et al., 2014): 
Ck
dt
dC
bio
'                        (3.11) 
where k’bio indicates the biotransformation rate (d-1). 
Based on experimental observations, a number of models explicitly consid-
ered the beneficial effect of growth substrate availability on XTC biotrans-
formation rates (Delgadillo-Mirquez et al., 2011; Plósz et al., 2012; Sathy-
amoorthy et al., 2013; Fernandez-Fontaina et al., 2014). This approach—also 
known as reductant model (Alvarez-Cohen and Speitel, 2001; Liu et al., 
2014)—was originally inspired by the model developed by Criddle (1993). 
Biotransformation was accordingly described (Eq. 3.12) as two-rate process 
in the presence (enhanced rate) and in the absence of growth substrate S:   
X
KC
Ck
KS
Sq
dt
dC
CS 




                  (3.12) 
where q and k are the maximum XTC utilization rate constants (gC gX-1 d-1) 
in the presence and in the absence of growth substrate, respectively. The pa-
rameter q lumps maximum growth rate (µmax, d-1), yield (Y, gX gS-1) over the 
growth substrate and the stoichiometric transformation yield (T, gC gS-1; Al-
varez-Cohen and Speitel, 2001) (Eq. 3.13): 
Y
Tq max                         (3.13) 
The concept of rate enhancement was justified by the regeneration of reduct-
ants (e.g., NADPH) used by oxidative enzymes via the degradation of growth 
substrates, thus providing a benefit for XTC biotransformation (Alvarez-
Cohen and Speitel, 2001). Simplified versions of Eq. 3.12 have been imple-
mented in the mentioned XTC fate models. Assuming pseudo-first-order ki-
netics with respect to XTC concentration (C<<KC), the reductant model (Eq. 
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3.14) was used to describe biotransformation in mixed culture (Plósz et al., 
2012) and nitrifying culture systems (Sathyamoorthy et al., 2013):  
CXk
KS
Sq
dt
dC
bio
S
C 


                   (3.14) 
where qC and kbio, defined as biotransformation rate constant (L gX-1 d-1)  in 
the presence and in the absence of growth substrate, are equivalent to q and k 
normalized by KC. Alternatively, under the assumption of non-limiting 
growth substrate availability, Fernandez-Fontaina et al. (2014) described bio-
transformation as a one-rate cometabolic process (Eq. 3.15): 
X
KC
C
KS
Sq
dt
dC
CS 





                  (3.15) 
Growth substrates can also compete with XTCs for the same nonspecific en-
zymatic sites, thus hindering XTC biotransformation rates (Alvarez-Cohen 
and Speitel, 2001). XTC biotransformation rate with competitive inhibition 
by growth substrate was accordingly described in Eq. 3.16 (Criddle, 1993; 
Orozco, 2008): 
X
K
KSKC
Ck
dt
dC
I
I
C 


 
                  (3.16) 
where KI (mgS L-1) is defined as inhibition constant. Plósz et al. (2010a) used 
a simplified version of Eq. 3.16 to describe competitive inhibition effects on 
XTC biotransformation (Eq. 3.17):  




 I
I
bio KS
K
CXk
dt
dC
                   (3.17)  
A non-competitive inhibition model was instead used to describe mixed sub-
strate utilization by specialist degraders (Eq. 3.18; Siegrist et al., 1989) 




 I
I
CC
C
KS
KX
KC
C
Ydt
dC max,                (3.18) 
Conversely, XTC inhibition of growth substrate utilization (competitive: 
Sathyamoorthy et al., 2013; non-competitive: Vasiliadou et al., 2013) has 
been also described—a less probable situation considering the significant 
concentration differences at environmental conditions (Liu et al., 2014).  
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Although limited experimental evidences exist, the temperature dependence 
of biotransformation rates or rate constants was implemented in a number of 
models (Joss et al., 2006b; Franco et al., 2011, 2013b) using the Arrhenius 
equation (Eq. 3.19):  
)( ref
ref
TT
TT kk
                        (3.19) 
where k denotes a generic biotransformation rate parameter (first-order rate, 
pseudo-first-order rate constant), Tref a reference temperature (typically 
20°C), T the actual temperature (°C), at which biotransformation was as-
sessed, and θ the Arrhenius coefficient (1.03–1.09: Joss et al., 2006b; 1.072: 
Franco et al., 2013b). Based on experimental evidences (e.g., Castiglioni et 
al., 2006), the impact of temperature on the biotransformation of furosemide 
in activated sludge was considered in Paper IV.  
Dependency of biotransformation rate constants from pH was further de-
scribed (Gulde et al., 2014) to account for cell uptake and thus biotransfor-
mation of only the neutral fraction of XTCs (Eq. 3.20): 
refpHnpH kk ,                        (3.20) 
where ϕn denotes the pH-dependent fraction of neutral XTC (Eq. 2.4) and 
kpH,ref the maximum theoretical rate constant when ϕn = 1. 
 
34
 
T
ab
le
 3
.1
. S
um
m
ar
y 
of
 m
od
el
s 
de
sc
ri
bi
ng
 th
e 
fa
te
 o
f X
TC
s 
in
 (b
io
lo
gi
ca
l) 
w
as
te
w
at
er
 tr
ea
tm
en
t s
ys
te
m
s.
 
 
 
Po
pu
la
r 
na
m
e 
St
at
e 
S S 
D
 
Pr
oc
es
se
s 
Sc
al
e 
of
 a
pp
lic
at
io
n 
/ 
Sy
st
em
 b
ou
nd
ar
ie
s 
R
ed
ox
 
co
nd
 
XT
C
s 
Pa
ra
m
et
er
 
so
ur
ce
 
N
ot
es
 
B
io
tr
an
sf
B
io
de
g 
So
rp
/D
es
 
R
et
ra
ns
f 
Vo
la
til
/ 
St
rip
p 
Io
ni
z 
O
th
er
 
La
b 
Pi
lo
t 
Fu
ll 
1.
 M
ul
tim
ed
ia
 
m
od
el
s 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S
tru
jis
 e
t a
l. 
(1
99
1)
 
S
im
pl
e 
Tr
ea
t 
 Fu
ga
ci
ty
 
 
 
Fi
rs
t-o
rd
er
 
T 
co
rre
ct
io
n 
 L
in
ea
r 
 
 
O
pt
io
na
l 
 
 
 
 
A
er
 
H
al
og
en
at
ed
 
hy
dr
oc
ar
bo
ns
 
S
ur
fa
ct
an
ts
 
P
ha
rm
ac
eu
-
tic
al
s 
Fr
ag
ra
nc
es
 
Li
te
ra
tu
re
  
S
or
p/
D
es
 a
nd
 
V
ol
at
il 
on
ly
 fo
r 
ne
ut
ra
l s
pe
ci
es
 
S
tru
jis
 (1
99
6)
 
v.
 3
.0
 
 
 
 
 
 
 
E
C
 (2
00
4)
 
v.
 3
.1
 
 
Fi
rs
t-o
rd
er
 
or
  
M
on
od
-
ba
se
d 
Sp
ec
ia
lis
t 
de
gr
ad
er
s 
 
T 
co
rre
ct
io
n 
 
 
 
 
 
K o
w
-b
as
ed
 
re
gr
es
si
on
s 
fo
r 
K
oc
 (S
ab
lijc
 e
t a
l.,
 
19
95
) 
Fr
an
co
 e
t a
l. 
(2
01
3a
,b
) 
v.
 3
.2
 
 
 
 
 
 
 
 
C
on
tin
uo
us
-
flo
w
 
ex
pe
rim
en
ts
 
R
ev
is
ed
 
re
gr
es
si
on
s 
fo
r 
so
rp
tio
n 
of
 
io
ni
ze
d 
sp
ec
ie
s 
S
tru
ijs
 (2
01
4)
 
v.
 4
.0
 
 
 
 
 
 
 
 
Li
te
ra
tu
re
 
A
rto
la
-G
ar
ic
an
o 
et
 a
l. 
(2
00
3b
) 
S
im
pl
e 
Tr
ea
t 3
.0
 
Fu
ga
ci
ty
 
 
 
Fi
rs
t-o
rd
er
 
 
Li
ne
ar
 
 
 
 
 
 
 
 
A
er
 
Fr
ag
ra
nc
es
 
B
at
ch
 
ex
pe
rim
en
ts
 
 
C
la
rk
 e
t a
l. 
(1
99
5)
 
ST
P 
Fu
ga
ci
ty
 
 
 
 F
irs
t-o
rd
er
 
Li
ne
ar
 
 
 
 
 
 
 
 
A
er
 
Ar
om
at
ic
s 
P
AH
s 
H
al
og
en
at
ed
 
hy
dr
oc
ar
bo
n 
P
he
no
ls
 
Pe
st
ic
id
es
 
Li
te
ra
tu
re
 
Ph
as
es
 in
 e
ac
h 
ta
nk
 (a
ir,
 w
at
er
, 
so
lid
s)
 in
 
eq
ui
lib
riu
m
. 
Bi
ot
ra
ns
f i
n 
so
lid
 
ph
as
e 
K
ha
n 
an
d 
O
ng
er
th
 (2
00
4)
 
ST
P 
Fu
ga
ci
ty
 
 
 
 
Fi
rs
t-o
rd
er
 
 
Li
ne
ar
 
(In
-s
ew
er
 
co
m
pl
et
e 
de
co
nj
ug
a-
tio
n)
 
N
eg
lig
. 
 
 
 
 
+ 
E
xc
re
-
tio
n 
an
d 
se
w
er
 
A
er
 
P
ha
rm
ac
eu
-
tic
al
s 
Li
te
ra
tu
re
, 
so
ftw
ar
e 
es
tim
at
io
n 
S
or
p/
D
es
 o
nl
y 
fo
r 
ne
ut
ra
l s
pe
ci
es
 
S
et
h 
et
 a
l. 
(2
00
8)
 
ST
P-
EX
 
(U
pd
at
e 
of
 S
TP
 
an
d 
S
im
pl
e 
Tr
ea
t 3
.0
) 
Fu
ga
ci
ty
 
 
 
 
Fi
rs
t-o
rd
er
 
 
Li
ne
ar
 
 
 
 
 
 
 
 
A
er
 
VO
C
s 
P
he
no
ls
 
P
AH
s 
P
ht
ha
la
te
s 
P
es
tic
id
es
 
H
al
og
en
at
ed
 
hy
dr
oc
ar
bo
ns
 
Li
te
ra
tu
re
 
an
d 
ex
pe
rt 
es
tim
at
io
n 
B
io
tra
ns
f i
n 
aq
ue
ou
s,
 s
or
be
d 
or
 b
ot
h 
ph
as
es
. 
S
or
p/
D
es
 a
nd
 
V
ol
at
il.
 o
nl
y 
fo
r 
ne
ut
ra
l s
pe
ci
es
 
Fr
an
co
 e
t a
l. 
(2
01
1)
 
Ac
tiv
ity
 
S
im
pl
e 
Tr
ea
t  
Ac
tiv
ity
 
 
 
Fi
rs
t-o
rd
er
 
or
 M
on
do
-
ba
se
d 
Sp
ec
ia
lis
t 
de
gr
ad
er
s 
 
Li
ne
ar
 
 
 
 
 
 
 
 
A
er
 
 
 
S
or
p 
of
 n
eu
tra
l 
an
d 
io
ni
c 
sp
ec
ie
s 
(F
ra
nc
o 
an
d 
Tr
ap
p,
 2
00
8;
 
Fr
an
co
 e
t a
l.,
 
20
09
) 
C
un
ni
ng
ha
m
 e
t 
al
. (
20
12
) 
P
hA
TE
 
Fu
ga
ci
ty
 
 
 
Fi
rs
t-o
rd
er
 
Li
ne
ar
 
 
 
 
 
 
 
 
A
er
 
E
st
ro
ge
ns
 
P
ha
rm
ac
eu
ti-
ca
ls
  
Li
te
ra
tu
re
 
E
xt
en
si
on
 o
f 
Ph
AT
E 
w
ith
 
Si
m
pl
eT
re
at
 3
.1
 
35
 
 
 
 
Po
pu
la
r 
na
m
e 
St
at
e 
S S 
D
 
Pr
oc
es
se
s 
Sc
al
e 
of
 a
pp
lic
at
io
n 
/ 
Sy
st
em
 b
ou
nd
ar
ie
s 
R
ed
ox
 
co
nd
. 
XT
C
s 
Pa
ra
m
et
er
 
so
ur
ce
 
N
ot
es
 
B
io
tr
an
sf
B
io
de
g 
So
rp
/D
es
 
R
et
ra
ns
f 
Vo
la
til
/ 
St
rip
p 
Io
ni
z 
O
th
er
 
La
b 
Pi
lo
t 
Fu
ll 
2.
 C
on
ce
nt
ra
tio
n-
ba
se
d 
m
od
el
s 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
am
ku
ng
 a
nd
 
R
itt
m
an
n 
(1
98
7)
 
 
C
on
c 
(S
, q
) 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
Li
ne
ar
 
 
 
 
 
 
 
 
A
er
 
Ar
om
at
ic
s,
 
H
al
og
en
at
ed
 
hy
dr
oc
ar
bo
ns
 
Li
te
ra
tu
re
 
Sc
en
ar
io
 
si
m
ul
at
io
ns
 
V
al
id
at
io
n 
w
ith
 
W
W
TP
 d
at
a 
S
ie
gr
is
t e
t a
l. 
(1
98
9)
 
 
C
on
c 
(S
N
TA
, 
X N
TA
, 
X B
,N
TA
) 
 
 
 
Sp
ec
ia
lis
t 
de
gr
ad
er
s 
M
on
od
-
ba
se
d 
Pr
im
ar
y 
su
bs
tra
te
 
in
hi
bi
tio
n 
 
Li
ne
ar
 
 
 
 
 
 
 
 
Ae
r (
N
) 
D
et
er
ge
nt
 
bu
ild
er
s 
Li
te
ra
tu
re
 
Ba
tc
h 
ex
pe
rim
en
ts
 
(s
or
pt
io
n)
 
A
SM
1 
ex
te
ns
io
n 
 
B
irc
h 
(1
99
1)
 
 
C
on
c 
(S
) 
 
 
Sp
ec
ia
lis
t 
de
gr
ad
er
s 
M
on
od
-
ba
se
d 
 
 
 
 
 
 
 
 
Ae
r (
N
) 
S
ur
fa
ct
an
ts
 
D
et
er
ge
nt
 
bu
ild
er
s 
C
on
tin
uo
us
-
flo
w
 
ex
pe
rim
en
ts
 
XT
C
s 
gr
ow
th
 
su
bs
tra
te
s 
C
ow
an
 e
t a
l. 
(1
99
3)
 
W
W
-
TR
E
AT
 
C
on
c 
(C
, C
s, 
C
t) 
 
 
Fi
rs
t-o
rd
er
 
 
Li
ne
ar
 
 
 N
eg
lig
. 
 
 
 
 
 
A
er
 
S
ur
fa
ct
an
ts
 
D
et
er
ge
nt
 
bu
ild
er
s 
Li
te
ra
tu
re
 
Ba
tc
h 
ex
pe
rim
en
ts
 
Bi
ot
ra
ns
f o
f 
aq
ue
ou
s 
an
d 
so
rb
ed
 c
on
c 
 
M
el
ce
r e
t a
l. 
(1
99
4)
, M
on
te
ith
 
et
 a
l. 
(1
99
5)
 
TO
X 
C
H
EM
 
C
on
c 
(C
, q
) 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
Li
ne
ar
 
 
 
 
 
 
 
 
A
er
 
H
al
og
en
at
ed
  
hy
dr
oc
ar
bo
ns
 
A
ro
m
at
ic
s 
Pe
st
ic
id
es
  
P
ilo
t-s
ca
le
 
ex
pe
rim
en
ts
 
 
By
rn
s 
(2
00
1)
 
 
C
on
c 
(C
w
) 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
Li
ne
ar
 
 
 
 
 
 
 
 
A
er
 
Ar
om
at
ic
s,
 
PA
H
, 
H
al
og
en
at
ed
 
hy
dr
oc
ar
bo
ns
 
In
se
ct
ic
id
es
 
O
nl
y 
si
m
ul
at
io
n 
st
ud
y 
Sc
en
ar
io
 
si
m
ul
at
io
ns
 in
 
id
ea
l W
W
TP
 
A
rto
la
-G
ar
ic
an
o 
et
 a
l. 
(2
00
3a
) 
 
C
on
c 
(C
fre
e, 
C
oc
, 
C
to
ta
l) 
 
 
Fi
rs
t-o
rd
er
 
Li
ne
ar
 
 
 
 
 
 
 
 
A
er
 
Fr
ag
ra
nc
es
 
Ba
tc
h 
ex
pe
rim
en
ts
 
M
od
el
 c
al
ib
ra
tio
n 
to
 m
ea
su
re
d 
aq
ue
ou
s 
an
d 
to
ta
l 
co
nc
 
Jo
ss
 e
t a
l. 
(2
00
4)
 
 
C
on
c 
(C
W
,b
ul
k, 
C
S)
 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
Li
ne
ar
 
E2

E1
, 
E1

E2
 
D
ec
on
ju
-
ga
tio
n 
Ps
eu
do
-
fir
st
-o
rd
er
 
 
 
 
 
 
 
Ae
r (
N
) 
 A
no
x 
A
na
er
 
Es
tro
ge
ns
  
Ba
tc
h 
ex
pe
rim
en
ts
 
 
U
ra
se
 a
nd
 K
ik
ut
a 
(2
00
5)
 
Tw
o-
ph
as
e 
m
od
el
 
C
on
c 
(C
W
, C
S)
 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
Li
ne
ar
 
Ps
eu
do
-
fir
st
-o
rd
er
 
(E
2
E1
) 
 
 
 
 
 
 
A
er
  
Es
tro
ge
ns
 
E
nd
oc
rin
e 
di
sr
up
te
rs
  
P
ha
rm
ac
eu
-
tic
al
s 
Fr
ag
ra
nc
es
 
Ba
tc
h 
ex
pe
rim
en
ts
 
Bi
ot
ra
ns
f o
f 
so
rb
ed
 c
on
c.
 
M
od
el
 a
pp
lic
at
io
n 
to
 E
BP
R
  
Xu
e 
et
 a
l. 
(2
01
0)
 
 
 
 
 
 
 
 
 
 
A
er
 (N
) 
A
no
x 
A
na
er
 
Ba
tc
h/
fu
ll-
sc
al
e 
ex
pe
rim
en
ts
  
36
 
 
 
Jo
ss
 e
t a
l. 
(2
00
6a
,b
) 
 
C
on
c 
(S
, X
, 
C
ai
r) 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
Li
ne
ar
 
 
 
 
 
 
 
 
Ae
r (
N
) 
Ph
ar
m
ac
eu
ti-
ca
ls
 
X-
ra
y 
co
nt
ra
st
 
m
ed
ia
 
Ba
tc
h 
ex
pe
rim
en
ts
 
W
W
TP
 re
m
ov
al
 
sc
en
ar
io
s.
 
Ap
pl
ic
at
io
n 
by
 
M
au
re
r e
t a
l. 
(2
00
7)
, A
be
gg
le
n 
et
 a
l. 
(2
00
9)
 
Li
nd
bl
om
 e
t a
l. 
(2
00
6)
 
 
C
on
c 
(S
XO
C
, 
X
XO
C
, 
X B
,X
O
C
) 
 
 
Sp
ec
ia
lis
t 
de
gr
ad
er
s,
 
M
on
od
-
ba
se
d 
  
Li
ne
ar
 
 
 
 
 
 
 
+ 
 
se
w
er
 
Ae
r  
En
do
cr
in
e 
di
sr
up
te
rs
  
PA
H
 
O
nl
y 
m
od
el
lin
g 
st
ud
y 
AS
M
1 
+ 
W
AT
S 
ex
te
ns
io
n 
 
G
ro
w
th
 o
n 
XT
C
s,
 
pr
im
ar
y 
su
bs
tra
te
 
Li
nd
bl
om
 e
t a
l. 
(2
00
9)
 
 
C
on
c 
(S
XO
C
, 
X
XO
C
, 
X B
,X
O
C
) 
 
 
Sp
ec
ia
lis
t 
de
gr
ad
er
s,
 
M
on
od
-
ba
se
d 
 
Li
ne
ar
 
 
 
 
 
 
 
 
Ae
r (
N
) 
En
do
cr
in
e 
di
sr
up
te
rs
 
C
on
tin
uo
us
-
flo
w
 
ex
pe
rim
en
ts
 
AS
M
1 
ex
te
ns
io
n.
 
G
ro
w
th
 o
n 
XT
C
s 
on
ly
 
W
ic
k 
et
 a
l. 
(2
00
9)
 
 
C
on
c 
(C
w
) 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
T 
co
rr
ec
tio
n 
N
eg
lig
. 
 
 
 
 
 
 
 
Ae
r (
N
)  
An
ox
 
Ph
ar
m
ac
eu
ti-
ca
ls
 
Ba
tc
h 
ex
pe
rim
en
ts
 
An
ox
 re
m
ov
al
 
w
ith
 s
ce
na
rio
 
si
m
ul
at
io
n 
Su
ar
ez
 e
t a
l. 
(2
01
0)
 
 
C
on
c 
(C
di
ss
ol
ve
d
C
to
t, 
C
ai
r) 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
Li
ne
ar
 
 
 
 
 
 
 
 
Ae
r (
N
)  
An
ox
 
Es
tro
ge
ns
, 
Ph
ar
m
ac
eu
ti-
ca
ls
 
Fr
ag
ra
nc
es
C
on
tin
uo
us
-
flo
w
 
ex
pe
rim
en
ts
 
Es
tim
at
io
n 
of
 
el
im
in
at
io
n 
pa
th
w
ay
s 
Pl
ós
z 
et
 a
l. 
(2
01
0,
 2
01
2)
 
AS
M
-X
 
C
on
c 
(C
LI
, 
C
SL
, 
C
C
J, 
C
SI
) 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
  
Pr
im
ar
y 
su
bs
tra
te
 
en
ha
nc
. o
r 
in
hi
bi
tio
n 
 
Li
ne
ar
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
 
 
Se
qu
e-
st
ra
tio
n 
in
 
so
lid
s 
 
 
 
Ae
r (
N
), 
An
ox
 
Ph
ar
m
ac
eu
ti-
ca
ls
 
Ba
tc
h 
ex
pe
rim
en
ts
, 
fu
ll-
sc
al
e 
sa
m
pl
in
g 
AS
M
1 
ex
te
ns
io
n.
 
Ap
pl
ic
at
io
n 
in
 
in
te
gr
at
ed
 fu
ll-
sc
al
e 
sy
st
em
s 
by
 
Sn
ip
 e
t a
l. 
(2
01
4)
. 
D
el
ga
di
llo
-
M
irq
ue
z 
et
 a
l. 
(2
01
1)
 
Fo
ur
 
co
m
pa
rt-
m
en
t 
m
od
el
 
C
on
c 
(C
f, 
C
g, 
c D
C
M
, c
P)
 
 
 
M
on
od
-
ba
se
d 
Pr
im
ar
y 
su
bs
tra
te
 
en
ha
nc
. 
Li
ne
ar
 
So
rp
tio
n 
to
 
pa
rti
cl
es
 
an
d 
D
C
M
 
 
 
 
 
 
 
 
An
ae
r 
PA
H
 
C
on
tin
uo
us
-
flo
w
 
ex
pe
rim
en
ts
 
Ap
pl
ic
at
io
n 
fo
r 
an
ae
r d
ig
es
tio
n 
Bi
ot
ra
ns
f o
f 
aq
ue
ou
s 
co
nc
 
(d
is
so
lv
ed
 +
 
so
rb
ed
 o
n 
D
C
M
) 
O
ttm
ar
 e
t a
l. 
(2
01
2)
 
 
C
on
c 
(C
, S
) 
 
 
Ze
ro
-o
rd
er
 
or
 p
se
ud
o-
fir
st
-o
rd
er
 
Pr
im
ar
y 
su
bs
tra
te
 
en
ha
nc
.
 
Li
ne
ar
 
 
 
 
 
 
 
 
Ae
r 
Ph
ar
m
ac
eu
ti-
ca
ls
 
C
on
tin
uo
us
-
flo
w
 a
nd
 
ba
tc
h 
ex
pe
rim
en
ts
 
Ex
te
ns
io
n 
of
 A
SM
 
m
od
el
 fo
r C
O
D
 
re
m
ov
al
 o
nl
y 
S
at
hy
am
oo
rth
y 
et
 a
l. 
(2
01
3)
 
 
C
on
c 
(S
P
hA
C
) 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
Pr
im
ar
y 
su
bs
tra
te
 
en
ha
nc
.  
Li
ne
ar
 
 
 
 
 
 
 
 
Ae
r (
N
) 
Ph
ar
m
ac
eu
ti-
ca
ls
 
Ba
tc
h 
ex
pe
rim
en
ts
 
Ex
te
ns
io
n 
of
 A
SM
 
m
od
el
 fo
r t
w
o-
st
ep
 n
itr
ifi
ca
tio
n.
 
XT
C
 in
hi
bi
tio
n 
of
 
N
H
4 o
xi
da
tio
n 
Va
si
lia
do
u 
et
 a
l. 
(2
01
3)
 
 
C
on
c 
(C
, C
*)
 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
Li
ne
ar
 
 
 
 
 
 
 
 
Ae
r (
N
) 
Ph
ar
m
ac
eu
ti-
ca
ls
 
Ba
tc
h 
an
d 
se
qu
en
ci
ng
-
ba
tc
h 
ex
pe
rim
en
ts
 
Ex
te
ns
io
n 
of
 
pr
oc
es
s 
m
od
el
 fo
r 
si
m
ul
ta
ne
ou
s 
gr
ow
th
 (C
O
D
, N
) 
XT
C
 in
hi
bi
tio
n 
of
 
bi
om
as
s 
gr
ow
th
  
Va
si
lia
do
u 
et
 a
l. 
(2
01
4)
 
 
 
 
 
 
 
D
iff
us
io
n 
in
 b
io
fil
m
 
 
 
 
37
 
 
A
bb
re
vi
at
io
ns
: C
on
c 
= 
co
nc
en
tr
at
io
n;
 S
S
 =
 s
te
ad
y-
st
at
e;
 D
 =
 d
yn
am
ic
; B
io
tr
an
sf
 =
 b
io
tr
an
sf
or
m
at
io
n;
 B
io
de
g 
= 
bi
od
eg
ra
da
tio
n;
 S
or
p/
D
es
 =
 s
or
pt
io
n/
de
so
rp
tio
n;
 R
et
ra
ns
f =
 r
et
ra
ns
fo
r-
m
at
io
n;
 V
ol
at
il/
S
tr
ip
p 
= 
vo
la
til
iz
at
io
n/
st
rip
pi
ng
; I
on
iz
 =
 io
ni
za
tio
n;
 R
ed
ox
 c
on
d 
= 
R
ed
ox
 c
on
di
tio
ns
; T
 c
or
re
ct
io
n 
= 
te
m
pe
ra
tu
re
 c
or
re
ct
io
n;
 A
er
 =
 a
er
ob
ic
; A
er
 (
N
) 
= 
ae
ro
bi
c 
(n
itr
ifi
yi
ng
);
 
A
no
x 
= 
an
ox
ic
; A
na
er
 =
 a
na
er
ob
ic
; e
nh
an
c.
 =
 e
nh
an
ce
m
en
t; 
N
eg
lig
. =
 n
eg
lig
ib
le
; P
A
H
 =
 p
ol
yc
yc
lic
 a
ro
m
at
ic
 h
yd
ro
ca
rb
on
s;
 E
1 
= 
es
tr
on
e;
 E
2 
= 
17
β-
es
tra
di
ol
; A
S
M
 =
 A
ct
iv
at
ed
 S
lu
dg
e 
M
od
el
; D
C
M
 =
 d
is
so
lv
ed
 a
nd
 c
ol
lo
id
al
 m
at
te
r.
 
A
dd
iti
on
al
 n
ot
es
: 
re
le
va
nt
 p
ro
ce
ss
 r
at
es
 o
r 
ex
pr
es
si
on
s 
fo
r 
bi
ot
ra
ns
fo
rm
at
io
n/
bi
od
eg
ra
da
tio
n 
an
d 
so
rp
tio
n 
ar
e 
in
cl
ud
ed
 i
n 
th
e 
re
sp
ec
tiv
e 
bo
x 
fo
r 
ea
ch
 m
od
el
. 
Fo
r 
bi
ot
ra
ns
fo
r-
m
at
io
n/
bi
od
eg
ra
da
tio
n,
 t
he
 n
ot
at
io
ns
 ‘F
irs
t-o
rd
er
’ (
E
q.
 2
.1
4)
, 
‘P
se
ud
o-
fir
st
-o
rd
er
’ (
E
q.
 2
.1
2–
2.
13
) 
an
d 
‘M
on
od
-b
as
ed
’ (
E
q.
 2
.1
1)
 r
ef
er
 t
o 
th
e 
ex
pr
es
si
on
s 
us
ed
 w
ith
 r
es
pe
ct
 t
o 
X
TC
s 
re
ga
rd
le
ss
 o
f 
ot
he
r 
te
rm
s 
in
 t
he
 r
at
e 
eq
ua
tio
ns
 u
se
d.
 T
he
 a
dd
iti
on
al
 n
ot
at
io
ns
 ‘P
rim
ar
y 
su
bs
tra
te
 e
nh
an
ce
m
en
t’ 
an
d 
‘P
rim
ar
y 
su
bs
tr
at
e 
in
hi
bi
tio
n’
 r
ef
er
 t
o 
th
e 
in
cl
us
io
n 
of
 a
dd
iti
on
al
 
te
rm
s 
in
 th
e 
ra
te
 e
qu
at
io
n 
ac
co
rd
in
g 
to
 E
q.
 2
.1
5–
2.
18
 a
nd
 E
q.
 2
.1
9–
2.
21
, r
es
pe
ct
iv
el
y.
 
  
Ve
zz
ar
o 
et
 a
l. 
(2
01
4)
 
(s
ee
 a
ls
o 
D
e 
Ke
ys
er
 e
t a
l.,
 
20
10
; C
lo
ut
ie
r e
t 
al
., 
20
12
) 
IU
W
S_
 
M
P
 
C
on
c 
(S
M
P
, 
X M
P)
 
 
 
 
Fi
rs
t-o
rd
er
 
Li
ne
ar
 
 
 
 
H
yd
ro
ly
si
s 
Se
ttl
in
g 
Fi
ltr
at
io
n 
Ph
ot
ol
ys
is
 
 
 
+ 
Se
w
er
 
Sl
ud
ge
 
tre
at
m
. 
R
iv
er
 
fa
te
 
Ae
r (
N
) 
An
ox
 
An
ae
r 
Pl
as
tic
iz
er
s 
En
do
cr
in
e 
di
sr
up
te
rs
 
H
er
bi
ci
de
s 
PA
H
 
Es
tro
ge
ns
 
 
Ex
te
ns
io
n 
of
 
AS
M
2d
 a
nd
 fa
te
 
m
od
el
s 
(s
ew
er
s,
 
riv
er
s,
 s
lu
dg
e,
 
st
or
m
w
at
er
) 
Sc
en
ar
io
 
si
m
ul
at
io
ns
 w
ith
 
id
ea
l (
be
nc
h-
m
ar
k)
 W
W
TP
  
Fe
rn
an
de
z-
Fo
nt
ai
na
 e
t a
l. 
(2
01
4)
 
 
C
on
c 
(C
W
, C
S
) 
 
 
 
M
on
od
-
ba
se
d,
 
Pr
im
ar
y 
su
bs
tra
te
 
en
ha
nc
.
Li
ne
ar
 
 
 
 
 
 
 
 
Ae
r (
N
)  
Ph
ar
m
ac
eu
ti-
ca
ls
 
Fr
ag
ra
nc
es
 
C
on
tin
uo
us
-
flo
w
 
ex
pe
rim
en
ts
 
Ex
te
ns
io
n 
of
 
AS
M
1-
ba
se
d 
ni
tri
fic
at
io
n 
m
od
el
  
(m
ea
su
re
d 
ni
tri
fic
at
io
n 
ra
te
) 
G
ul
de
 e
t a
l. 
(2
01
4)
 
 
C
on
c 
(C
W
, C
t) 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
Li
ne
ar
 
 
 
 
Ab
io
tic
 
tra
ns
f 
(F
irs
t-
or
de
r) 
 
 
 
Ae
r  
Ph
ar
m
ac
eu
ti-
ca
ls
 
Pe
st
ic
id
es
 
Fu
ng
ic
id
es
 
Ba
tc
h 
ex
pe
rim
en
ts
 
Io
ni
za
tio
n 
pa
tte
rn
s 
us
ed
 to
 
re
-in
te
rp
re
t 
es
tim
at
ed
 k
Bi
o a
t 
di
ffe
re
nt
 p
H
 
Po
m
ié
s 
et
 a
l. 
(2
01
5)
 
 
C
on
c 
(S
m
p, 
X m
p)
 
 
 
 
Ps
eu
do
-
fir
st
-o
rd
er
 
Pr
im
ar
y 
su
bs
tra
te
 
en
ha
nc
. o
r  
in
hi
bi
tio
n 
Li
ne
ar
 
 
 
 
 
 
 
 
Ae
r (
N
) 
An
ox
 
Ph
ar
m
ac
eu
ti-
ca
ls
 
Ba
tc
h 
ex
pe
rim
en
ts
 
Bi
ot
ra
ns
f o
f 
aq
ue
ou
s 
an
d 
so
rb
ed
 c
on
c.
 
In
hi
bi
tio
n/
en
ha
nc
. 
sw
itc
h 
fu
nc
tio
ns
 
de
pe
nd
in
g 
on
 
co
nd
iti
on
s 
te
st
ed
 
38 
3.4 Beyond wastewater treatment: fate modelling 
in agricultural systems 
As outlined in Chapter 1, XTCs can be released to agricultural systems via 
fertilization with manure or WWTP biosolids and/or irrigation with freshwa-
ter or reclaimed wastewater. In soil, XTC fate is essentially characterized by 
processes similar to the ones occurring during wastewater treatment: sorption 
and sequestration to solid matrices (soil organic matter and minerals), micro-
bial and abiotic degradation (e.g., photolysis), and volatilization (when rele-
vant). In addition, XTCs undergo advective transport with soil pore water, 
which can result in downward leaching to groundwater or uptake into plants 
via transpiration. Distribution into different plant compartments results from 
the transport of water and nutrients through the plant and mainly depends on 
XTC properties (e.g., ionization pattern, partitioning capacity) (Trapp, 2009). 
Although experimental evidences are still scarce, XTCs are likely metabo-
lized and thus degraded in plants (Komossa et al., 1995). 
In this PhD thesis, a dynamic soil-plant model was applied to predict the fate 
of ionizable XTCs and their uptake in winter wheat (Paper IV). The model 
includes previously listed fate processes by combining a tipping buckets wa-
ter balance model (Trapp and Matthies, 1998) and a dynamic plant uptake 
model (Legind et al., 2011, 2012; Rein et al., 2011; Trapp and Eggen, 2013). 
A schematic presentation of the simulated system is given in Fig. 3.2, consid-
ering winter wheat as the investigated crop.  
The thickness of an ideal soil volume (1 m) is discretized into five layers 
which are simulated as tipping buckets. Each layer is characterized by an up-
per and a lower limit for water storage, described by the field capacity and 
the permanent wilting point, respectively. Downward transport of dissolved 
XTCs follows downward water movement, which is determined by the water 
content of each layer. If the water content soil layer reaches field capacity, 
transport of water and dissolved XTCs occurs to the layer underneath. Con-
currently, upward transport of water and dissolved XTCs occurs via transpi-
ration to the plant (and, if relevant, subsequent evaporation). The dissolved 
XTC fraction is calculated based on the solid-liquid partition coefficient Kd in 
soil. The overall mass balance of the dissolved XTC fraction in soil includes: 
(i) input via sludge application or irrigation to topsoil (layer 1); (ii) leaching 
from upper layers (layers 2-5) and losses via leaching to lower layers or to 
groundwater (layers 1–5); (iii) transpiration to plant roots from each layer; 
(iv) sorption and biological degradation (first-order temperature-dependent 
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kinetics) in each layer. Transpiration to plant is simulated as a function of 
plant growth.  
A cascade approach is used to solve analytically differential equations for the 
distribution of uptaken XTC into different compartments of the wheat plant 
(roots, stem, leaves and grains). Intra-compartment transport of dissolved 
XTCs is simulated to occur via the two tissues transporting water and nutri-
ents in the plant, i.e. xylem (soil → roots → stem → leaves/grains) and phlo-
em (leaves → stem → grains). Water flux with the xylem is typically one to 
two orders of magnitude larger than with the phloem (Trapp and Matthies, 
1998; Rein et al., 2011). The mass balance for XTCs in each plant compart-
ment includes: (i) inward and outward transport (when relevant) with xylem 
and/or phloem; (ii) dilution effect due to plant growth; and (iii) partitioning 
between plant compartments and xylem/phloem. XTC partitioning eventually 
determines the extent of the distribution and is described using a cell model 
(Trapp, 2004). According to the cell model, plant compartments are subdivid-
ed into water, lipids and proteins, i.e. major components of plant cells (cyto-
sol and vacuoles). Overall, XTC partitioning between xylem/phloem and 
plant cells accounts for: (i) different pH conditions occurring in xylem, phlo-
em and cell compartments; (ii) different sorption capacity exhibited by neu-
tral and ionized XTC species; and (iii) the different affinities to cell lipids 
and proteins. With respect to (iii), equations have been defined to empirically 
estimate partition coefficients (L L-1) to lipids of neutral (Kn,lipid, Eq. 3.21) 
and ionized species (Ki,lipid, Eq. 3.22) (Trapp et al., 1994): 
b
nowlipidn KLK ,, 22.1                      (3.21) 
b
iowlipidi KLK ,, 22.1                      (3.22) 
and the partition coefficient to proteins (Kprotein, Eq. 3.23): 
HSAaprotein KPK ,                      (3.23) 
where L (kg kg-1) and P (mol L-1) denote the lipid and protein content in each 
compartment, 1.22 is the density ratio between octanol and water, b accounts 
for the difference between octanol and plant lipids (0.77 for roots, 0.95 for 
stem, leaves and grains), Kow,n and Kow,i denote the octanol-water partition 
coefficient for neutral and ionized species, respectively, and Ka,HSA (L mol-1) 
defines the partition coefficient to human-serum albumin. The significance of 
adsorption to proteins was shown for a number of ionizable XTCs, being in-
fluential for their accumulation in plants (Macherius et al., 2012).  
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The dynamic soil-plant model was developed as a generic tool, requiring lim-
ited input (chemical properties, degradation rates) to predict plant uptake of 
XTCs in ideal scenarios. Nevertheless, the model found application in real 
scenarios through parameterization with soil and plant characteristics and 
weather data (Legind et al., 2012; Trapp and Eggen, 2013; Prosser et al., 
2014b; Trapp, 2015). Besides winter wheat, dynamic uptake models have 
been developed and tested for other plants, e.g., root vegetables (Trapp, 2009, 
2015) and fruit trees (Trapp, 2007). 
 
Figure 3.2. Schematic representation of the dynamic soil-plant uptake model, combining 
the tipping buckets water balance model and the dynamic plant uptake model. Solid arrows 
represent the main input and transport pathways for XTCs in the soil-plant system. 
  
Grains 
Irrigation 
Sludge 
application 
Layer 1 
Layer 2 
Layer 3 
Layer 4 
Layer 5 
Groundwater 
Leaves 
Roots 
Stem 
Leaching and 
transpiration 
Xylem flux 
Phloem flux 
Biodegradation 
41 
4 Sorption of zwitterionic ciprofloxacin 
onto activated sludge 
Solid-liquid partitioning of ionizable XTCs onto solid matrices involves mul-
tiple mechanisms (2.2.2). Environmental conditions (pH, ionic strength) 
change the speciation of both sorbent and sorbate and can significantly influ-
ence partitioning of ionizable XTCs. Several studies focused on the im-
portance of these factors on the sorption of ionizable XTCs in soils, whereas 
limited evidence has been obtained for wastewater systems. In particular, 
sorption of zwitterionic substances has been rarely assessed. Antibiotics from 
several classes (fluoroquinolones, tetracyclines) are in fact zwitterionic and 
can exhibit anionic and cationic charges when ionized. In Paper I, we inves-
tigated the influence of pH and iron salt dosing on the partitioning onto acti-
vated sludge. Iron salt (FeCl3, FeSO4) is typically added during secondary 
treatment for chemical phosphorus removal. The fluoroquinolone antibiotic 
ciprofloxacin was selected as example of ionizable XTC. 
 
Figure 4.1. Ionized species of ciprofloxacin (pKa values: Kümmerer, 2009a). Although 
zwitterionic chemicals can be typically present both as uncharged molecules and zwitteri-
ons (overall defining the neutral configuration), the former configuration is typically ne-
glected for ciprofloxacin. 
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4.1 Properties of ciprofloxacin 
Ciprofloxacin is a widely used fluoroquinolone antibiotic. As a zwitterionic 
chemical, ciprofloxacin can speciate as anion (acid pKa=6.16), cation (base 
pKa=8.63) zwitterion or neutral chemical (Fig. 4.1). Under relevant pH condi-
tions, the neutral fraction is typically considered negligible as compared to 
the zwitterionic fraction (e.g., Kümmerer, 2009a), assuming KZ=∞ (Eq. 2.10). 
The neutral fraction is here considered equivalent to the zwitterionic fraction 
(ϕn = ϕ±, Eq. 2.6) 
Based on reported pKa values, the three ionized species (anion, cation and 
zwitterion) thus can be simultaneously present at pH conditions during sec-
ondary wastewater treatment (6.2–8.1: Helbling et al., 2012). Sorption of 
ciprofloxacin was found significant both in soils (Tolls, 2001; Thiele-Brun, 
2003) and activated sludge (Golet et al., 2003; Lindberg et al., 2006; Plósz et 
al., 2010a) despite its low hydrophobicity (logD=-3.01 at pH= 7.4; 
ACD/logD, ilab.acdlabs.com). Thus, other mechanisms than hydrophobic 
partitioning are likely involved in the sorption of ciprofloxacin (Tolls, 2001; 
Vasudevan et al., 2009). 
4.2 Experimental methods and results 
Sorption experiments were performed to determine sorption of ciprofloxacin 
onto activated sludge: (i) at different pH (3.0, 6.3, 7.4, 8.0 and 12.0) under 
aerobic conditions; and (ii) with and without iron salt (FeCl3, FeSO4) addition 
at different redox conditions (aerobic, anoxic and anaerobic) and pH=6.3. In 
each experiment, activated sludge (30 mL; 3.0 gTSS L-1) was spiked with 
ciprofloxacin at different initial concentrations (100–2400 µg L-1). Following 
incubation for 23 h at 21°C, the residual aqueous concentration of ciprofloxa-
cin was measured in filtered sludge supernatant (0.45 µm). The sorbed con-
centration of ciprofloxacin was determined as the difference between initial 
and final aqueous concentration, and sorption isotherms at different condi-
tions were accordingly derived. 
Experimental results are summarized in Figure 4.2 (a: pH influence; c: iron 
salt dosing influence). Freundlich equation (Eq. 2.2, n=0.67–1.33) was in all 
cases required to describe the sorption isotherms obtained (Fig. 4.2a,c). At 
typical wastewater pH (6.3–8.0), sorption was highly non-linear (n=0.67–
0.77), as also shown for other ionizable XTCs (Hyland et al., 2012). To fa-
cilitate a comparison between the several cases assessed, solid-liquid parti-
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tion coefficients Kd were estimated based on Freundlich equation at a theoret-
ical aqueous concentration of 10 µg L-1 (Fig. 4.2b,d).  
Sorption of ciprofloxacin onto activated sludge was significantly influenced 
by pH (Fig. 4.2a–b). Highest sorption (Kd=12.3 L gTSS-1) was found at the 
iso-electric point (pH=7.4), when ciprofloxacin was mostly present as zwit-
terion (Fig. 4.2b). Similar sorption capacity was shown at pH=6.3 and 8.0 
(Kd=3.7 L gTSS-1). Sorption at pH=3 (Kd=2.4 L gTSS-1) was considerably 
higher than at pH=12 (Kd=0.02 L gTSS-1), indicating the least sorption for the 
anionic species. Negligible sorption by anions was found for several XTCs 
(Urase and Kikuta, 2005; Franco and Trapp, 2008; Tülp et al., 2009). Con-
versely, the highest sorption capacity was exhibited by the zwitterion (Fig. 
4.2b).  
 
Figure 4.2. Sorption isotherms obtained at different pH (a) and different redox conditions 
with and without Fe salt addition (c). Kd values, estimated at the theoretical concentration 
CLI = 10 µg L-1, were compared to assess the effect of pH (b) and of Fe salt dosing at 
pH=6.3 (d). 
 
In the absence of iron salt addition, sorption under anoxic conditions (Kd=5.8 
L gTSS-1) was higher than estimated under aerobic conditions (Kd=4.4 L 
gTSS-1). Under both aerobic and anoxic conditions (Fig. 4.2c), the addition of 
Fe(II)- or Fe(III)-salts resulted in a consistent sorption increase (Kd=8.1 and 
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9.1 L gTSS-1, respectively), although lower when compared to the effect of 
pH. On the contrary, no sorption increase due to iron salt addition was shown 
under anaerobic conditions (see Paper I). Enhancement of sorption was ob-
served for other XTCs upon Fe and Al salt addition (Carballa et al., 2005). 
Overall, these findings suggested that ciprofloxacin sorbed onto activated 
sludge via hydrophobicity-independent mechanisms. Based on previous evi-
dences (Nowara et al., 1997; Gu and Karthikeyan, 2005; MacKay and Can-
terbury, 2005; Carrasquillo et al., 2008; Vasudevan et al., 2009; Pan et al., 
2012; MacKay and Vasudevan, 2012) and on our experimental observations, 
we proposed the following mechanisms to describe sorption of ciprofloxacin 
at different pH and iron salt dosing conditions (Fig. 4.3).  
Activated sludge surfaces typically carry negative charges due to the pres-
ence of anionic organic functional groups (Wang et al., 2000). Sludge surfac-
es thus exhibit high affinity for divalent cations (Ca2+ and Mg2+) (Sobeck and 
Higgins, 2002). At pH=6–9, ciprofloxacin is present in the three ionized spe-
cies. Cationic ciprofloxacin can sorb via Coulombic attraction onto negative-
ly charged surfaces and cation exchange of the protonated amines. These 
mechanisms can also cause sorption of zwitterions, due the favourable charge 
distribution within the molecules—areas of opposite charge are located at 
opposite ends (Carrasquillo et al., 2008). In addition, zwitterions (and anions) 
can sorb through cation bridging via divalent cations with the deprotonated 
carboxyl. Upon dosing, iron cations can bind to negatively charged sludge 
surfaces. Zwitterions (and anions) can form stable ternary complexes with 
bound Fe3+ and, partially, Fe2+, thus resulting in the observed increase of 
ciprofloxacin sorption. The extent of such increase depends on redox condi-
tions, determining the oxidation state of Fe. At pH<6, sorption of cationic 
ciprofloxacin (the only species present) is likely limited by the reduction of 
negative charges onto sludge surfaces (pKa=6.29; Wang et al., 2000). At 
pH>9, ciprofloxacin is speciated as anion, and Coulombic repulsion with 
negatively charged sludge surface significantly reduces the sorption capacity. 
We note that Coulombic repulsion of anionic ciprofloxacin may also predom-
inate over sorption via cation bridging and complexation at pH=6–9.   
It can be thus concluded that solid-liquid partitioning of ciprofloxacin is 
mainly an adsorption process (Schwarzenbach et al., 2003) determined to the 
greatest extent by the presence of the antibiotic as zwitterion. Zwitterionic 
ciprofloxacin can undergo sorption via multiple mechanisms, justifying our 
experimental observations. 
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Figure 4.3. Mechanisms proposed to describe sorption of ciprofloxacin at different pH and 
iron salt dosing conditions onto activated sludge (activated sludge floc: adapted from 
Comeau, 2008). 
 
4.3 Modelling implications 
Based on experimental results, extensions of the ASM-X framework are pro-
posed to describe sorption of ionizable XTCs. Experimental results showed 
the non-linearity of ciprofloxacin sorption under a range of conditions. 
Freundlich equation was required to describe sorption of other ionizable 
XTCs onto activated sludge (Hörsing et al., 2011; Hyland et al., 2012). 
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Freundlich-based sorption rate equation (Eq. 4.1) thus can be considered, 
e.g., as extension of ASM-X model:  
SS
n
LIfdesLI XCKkdtdC /                    (4.1) 
where kdes denotes the desorption rate (d-1). Eq. 4.1 can provide a generalized 
description of XTC sorption at low and high concentrations, which could be 
beneficial when considering short-term dynamics (e.g., in influent concentra-
tion). However, Eq. 4.1 increases the structural complexity of the model and 
its application may be challenging when pH significantly impacts sorption. 
An effective way of describing the influence of pH on partitioning is defined 
by separately accounting for linear sorption of different ionic species. For 
ciprofloxacin, the resulting Kd at different pH conditions would be according-
ly described using (Eq. 4.2):  
  ,,,)( dddd KKKpHK                 (4.2) 
where ϕ+, ϕ±, ϕ- identify the ionic fractions and Kd,+, Kd,±, Kd,- the partition 
coefficients of the cationic, zwitterionic and anionic species, respectively. No 
limitation of negative surface charge is considered, a reasonable assumption 
for pH conditions in activated sludge systems. Parameterization of Eq. 4.2 
(i.e., experimental determination of Kd,+, Kd,±, Kd,-) may be required at differ-
ent redox conditions and upon iron salt dosing. Eq. 4.2 can be applied to de-
scribe sorption of other ionizable XTCs having similar characteristics to 
ciprofloxacin (e.g., fluoroquinolones), with the possibility of neglecting Kd-. 
The partitioning submodel defined in Eq. 4.2 was further applied in Paper IV 
to predict the removal of ciprofloxacin in a generic WWTP. 
Overall, both model extensions are meant to provide a refined description of 
the solid-liquid partitioning of ciprofloxacin (and other zwitterionic XTCs) 
onto activated sludge, supporting observations of this and future experimental 
studies.  
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5 Biotransformation of XTCs in single- 
and three-stage pre-denitrifying MBBRs 
Conventional systems for biological wastewater treatment have been general-
ly proved not efficient in terms of XTC elimination. A number of innovative 
technologies and reactor design solutions have thus been investigated for the 
improvement of XTC removal. Among these solutions, staging of biological 
reactors has been hypothesized to optimize pollutant removal processes based 
on reaction kinetics principles (Scuras et al., 2001; Joss et al., 2006a; Plósz, 
2007; Grady et al., 2011). In staged ‘sub-reactors’, biomass is further exposed 
to significantly different substrate loading, availability and composition, as 
reactor staging induces a declining gradient in organic substrate loading and 
heterogeneity in the influent to subsequent sub-reactors. Such conditions may 
eventually lead to biomass adaptation or specialization, with improved utili-
zation kinetics as compared to single-stage reactors (Plósz and Vogelsang, 
2012). In addition, enhanced biotransformation kinetics were found for a 
number of XTCs in moving bed biofilm reactors (MBBRs), possibly resulting 
from prolonged biomass retention and enrichment of slowly growing bacteria 
(Falås et al., 2012, 2013).  
In Paper II, we investigated the elimination of pharmaceuticals in two labor-
atory-scale MBBR configurations, i.e. single-stage (U) and three-stage (S1 + 
S2 + S3) MBBRs (Fig. 5.1). The two systems were designed for denitrifica-
tion of pre-clarified municipal wastewater without addition of external COD 
and without spiking of XTCs. The three-stage MBBR configuration, designed 
according to Plósz (2007), could potentially combine the benefits of MBBRs 
and reactor staging in terms of XTC removal.  During continuous-flow opera-
tion, the two MBBR systems were: (i) run in parallel under the same continu-
ous-flow feeding conditions (pre-clarified municipal wastewater from 
Mølleåværket WWTP, Lundtofte, Denmark with external nitrate dosing); (ii) 
designed to have the same total operating volume (6 L), hydraulic residence 
time (8.9 h) and filling ratio (33%; K1 carriers, AnoxKaldnes, Lund, Swe-
den). Excess nitrate (KNO3, influent concentration = 103 mgN L-1) was con-
tinuously dosed to both MBBR systems in order to ensure non-limiting avail-
ability of electron acceptor. Nitrogen gas sparging was used for mechanical 
mixing of MBBR carriers and to minimize dissolved oxygen (DO) concentra-
tion in the medium. 
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During long-term operation (approximately	 1.5 years) of the two systems, 
two sets of batch experiments (batch 1: day 100; batch 2: day 471) were per-
formed with biofilm from each MBBR (U, S1, S2, S3). MBBRs were discon-
nected and experiments were run for 24 h (batch 1) or 49 h (batch 2) using 
the same initial feeding medium (pre-clarified wastewater from Mølleåværket 
WWTP and excess nitrate at initial concentration of 104 mgN L-1). Concen-
tration of bulk pollutants and pharmaceuticals were measured at regular in-
tervals during the experiments. 
 
Figure 5.1. Schematic presentation of the single-stage (U) and three-stage (S1, S2, S3) 
MBBRs. 
 
In this section, results from batch 2 are presented. Batch experiments aimed 
at characterizing biokinetics of heterotrophic denitrification and pharmaceuti-
cals elimination in each MBBR. Thus, the main goal of our investigation was 
to assess whether differences in denitrification and pharmaceutical removal 
capabilities were induced by prolonged biofilm exposure to different electron 
donor loading/availability conditions. Specifically, we tested two hypotheses: 
 A kinetic improvement of pharmaceutical biotransformation occurs under 
strongly limiting electron donor loading/availability (e.g., in S3) due to, 
e.g., mixed substrate utilization strategies; 
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 Electron donor loading/availability, by supporting the growth of denitrify-
ing bacteria, exerts a positive influence on the biotransformation kinetics 
of pharmaceuticals occurring via cometabolism. 
To test these two hypotheses, identification of appropriate model structures 
describing XTC removal during batch experiments was a crucial step. 
Through our investigation, we also aimed at assessing XTC biotransfor-
mation under denitrifying conditions, for which limited evidences are cur-
rently available (Plósz et al., 2010, 2012; Falås et al., 2013; Suarez et al., 
2010; Su et al., 2015) as compared to aerobic conditions. 
5.1 Modelling removal kinetics in batch 
experiments 
In the batch experiments performed with MBBR biofilm, typical profiles of 
aqueous XTC concentration were recognized (Fig. 5.2). 
 
Figure 5.2. Typical profiles of pharmaceutical concentrations during batch experiments 
(circles) and simulation results with calibrated model (red line): (a) biotransformation on-
ly; (b) enantioselective biotransformation; (c), (d) retransformation and biotransformation. 
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Preliminary model identification, based on the ASM-X framework, was thus 
required to describe observed profiles. Eventually, rate constants could be 
estimated by calibrating identified models to measurements and compared 
among different MBBRs. No effect of primary substrate (inhibition, reductant 
regeneration) was observed. Pseudo-first-order kinetics was considered with 
respect to aqueous XTC concentration. Model structures identified are sum-
marized in Table 5.1. Pseudo-first-order biotransformation was sufficient to 
describe removal kinetics only for a number of XTCs (Fig. 5.2a). Biotrans-
formation of the beta-blocker atenolol resulted from a faster and a slower 
transformation process (Fig. 5.2b). Stereoselective biotransformation of the 
two enantiomers of atenolol (C1, C2) was hypothesized based on previous ex-
perimental findings (Kasprzyk-Hordern and Baker, 2011; Vazquez-Roig et 
al., 2014). Formation of XTCs (Fig. 5.2c–d) was observed and associated to 
the retransformation of conjugated XTCs (e.g., sulfonamides, diclofenac; 
2.2.3). 
Table 5.1. Model structures identified to describe removal kinetics of XTCs during MBBR 
batch experiments. Equations refer to XTC profiles presented in Figure 5.2. 
Case Processes 
States 
Rate equation 
CLI C1 C2 CCJ 
Biotransformation 
only (Fig. 5.2a) 
Biotransformation 
of CLI 
-1    SSLI
SSd
bio XC
XK
k
1  
Enantioselective 
biotransformation 
(Fig. 5.2b) 
Biotransformation 
of enantiomer 1 -1 -1   SS
SSd
bio XC
XK
k
1
1,
1  
Biotransformation 
of enantiomer 2 -1  -1  SS
SSd
bio XC
XK
k
2
2,
1  
Biotransformation 
and retransfor-
mation (Fig. 5.2c, 
5.2d) 
Biotransformation 
of CLI 
-1    SSLI
SSd
bio XC
XK
k
1  
Formation of CLI 
+1 
(F)* 
 
  -1 SSCJdec XCk  
*In case the XTC has only one known retransformable conjugate, the stoichiometry coeffi-
cient F should be used, being equivalent to the ratio of the molecular weight of parent 
(MWLI) and conjugated (MWCJ) XTC. 
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5.2 Influence of primary metabolism on XTC bio-
transformation kinetics 
By calibrating models presented in Table 5.1 to batch experimental data, it 
was possible to estimate transformation rate constants (kbio, kbio,1, kbio,2, kdec) 
for selected XTCs in S1, S2, S3, U. Biofilm capacity of reducing nitrogen 
oxides was also assessed by determining the denitrification potential in dif-
ferent MBBRs. The denitrification potential (DNP, mgN gTSS-1; Eq. 5.1) was 
calculated over the duration of batch experiments based on initial and final 
measured NOX concentrations (mgN L-1): 
TSSfinalXX XNONODNP /)( ,0,                  (5.1) 
where XTSS denotes the TSS concentration (gTSS L-1) in MBBR reactors. 
NOX included NO3-N and NO2-N concentrations to account for nitrite accu-
mulation: (Ubay Çokgör et al., 1998; Eq. 5.2): 
NNONNONOX  23 6.0                  (5.2) 
In Figure 5.3, we present transformation rate constants of non-recalcitrant 
pharmaceuticals (kbio, kdec > 0.1 L gTSS-1 d-1) as a function of denitrification 
potential DNP in different MBBRs. Highest and lowest DNP values were ob-
served in S1 and S3, respectively. A strong correlation was shown for the se-
lected XTCs (sulfamethoxazole, erythromycin, trimethoprim; atenolol to a 
lower extent) between transformation rate constants and DNP in MBBR reac-
tors. These results indicate that the long-term exposure to different COD 
loading (resulting from reactor staging) and availability (S1 versus U) influ-
enced biofilm capacity of reducing nitrogen oxides and degrading XTCs. 
More in detail, simultaneous exposure of S1 biofilm to the highest COD load-
ing, heterogeneity and availability may have influenced the metabolic capaci-
ty to access a broad range of carbon sources, including pharmaceuticals. Such 
influence resulted in the observed enhancement of heterotrophic denitrifica-
tion and transformation kinetics for some of the pharmaceuticals investigated 
(kbio ≥ 1 L gTSS-1 d-1 for sulfamethoxazole, erythromycin, atenolol; Fig. 5.3). 
The positive correlation showed in Figure 5.3 further demonstrates that XTC 
biotransformation occurred via cometabolism, where heterotrophic denitrifi-
cation represented the primary metabolic process supporting microbial 
growth.  
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Figure 5.3. Correlation between estimated transformation rate constants (kbio, kdec) and denitrifi-
cation potential (DNP, Eq. 5.1) during batch experiments in different MBBR reactors. Denitrifi-
cation potential is here used as an indicator of primary metabolic processes in biofilm. 
 
With respect to the antibiotic sulfamethoxazole, it is worth highlighting that 
(i) retransformation—most probably from conjugated metabolites—was 
found significant (Fig. 5.2c; Fig. 5.3b); (ii) kbio values estimated in our study 
(in particular for S1) were higher  than for activated sludge (see Table 1 in 
Paper II; compare with Table S4 in Paper III). This may indicate that en-
hanced sulfamethoxazole elimination may occur in MBBR systems. The sig-
nificance of these two evidences on sulfamethoxazole elimination in full-
scale WWTPs is assessed in detailed in Chapter 6 and in Paper III.  
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6 Factors influencing full-scale XTC 
removal: the case of sulfamethoxazole 
Due to intensive research in the last two decades, a large number of scientific 
studies has presented measured removal efficiencies for XTCs in full-scale 
WWTPs. Reported removal efficiencies have been characterized by signifi-
cant variability for the same substance (see, e.g., review studies by Michael et 
al., 2013; Luo et al., 2014; see also Fig. 3 in Paper IV). Such variability can 
be attributed both to experimental approaches (e.g., sampling protocols) used 
in these studies and to differences in XTC fate processes, occurring in full-
scale WWTPs.  
As outlined in the previous sections, two crucial factors are likely to influ-
ence the elimination of XTCs in full-scale WWTPs, namely (i) retransfor-
mation processes (2.2.3), leading to the apparent formation of XTCs; and (ii) 
solid residence time (SRT) of operation, affecting XTC biotransformation 
capacity (2.2.1). When retransformation processes are relevant (e.g., in the 
presence of significant concentrations of conjugated metabolites), monitoring 
the concentration of parent XTCs may be insufficient, resulting in incomplete 
mass balance of the investigated chemical.  
In Paper III, we assessed the influence of retransformation processes and 
SRT on the observed elimination of XTCs during biological treatment in full-
scale WWTPs. We extended a recently developed methodology (Plósz et al., 
2012) and compared ASM-X predictions and international literature data on 
XTC removal efficiency.   
Figure 6.1. Schematic representation of a full-scale biological wastewater treatment con-
figuration, in which XTC removal efficiency was predicted or measured. Removal effi-
ciency calculations were performed based on influent (‘in’) and effluent (‘eff’) XTC con-
centrations of the aqueous parent fraction (CLI) and the retransformable fraction (CCJ). 
 
CLI,eff
CCJ,eff
CLI,in
CCJ,in
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Predicted and measured removal efficiencies were calculated using aqueous 
parent (CLI) and retransformable (CCJ) XTC concentrations in secondary in-
fluent (‘in’) and effluent (‘eff’) (Fig. 6.1). More specifically, we distinguished 
between (predicted or measured) parent XTC removal efficiency (ηLI, Eq. 
6.1): 
inLI
effLIinLI
inLI
effLIinLI
LI C
CC
M
MM
,
,,
,
,,                 (6.1) 
and total XTC removal efficiency (ηTOT, Eq. 6.2), accounting for retransform-
able XTC fractions: 
inCJinLI
effCJeffLIinCJinLI
inCJinLI
effCJeffLIinCJinLI
TOT CC
CCCC
MM
MMMM
,,
,,,,
,,
,,,,


    (6.2) 
where M and C denote XTC mass loads (g d-1) and concentrations (ng L-1), 
respectively. The impact of retransformation and SRT on XTC elimination 
was graphically assessed (and quantified) using operating plots as in Figure 
6.2. The figure summarizes the possible cases (1–4) arising from the compar-
ison of ASM-X predictions and literature data. 
 
Figure 6.2. Operating plots presenting ASM-X prediction curves of parent-based (ηLI) and 
total (ηTOT) removal efficiency. Numbers refer to the situations arising from the compari-
son of literature data points with ASM-X predictions (see description on the right). 
 
ASM-X suited the purpose of our assessment as: (i) the only model explicitly 
describing retransformation of XTCs, apart from estrogens (Table 3.1); (ii) a 
dynamic model, required to describe XTC fate in full-scale WWTPs (3.2). 
Importantly, the influence of experimental approaches on the quantification 
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of XTC elimination was adequately minimized. We performed a selection of 
literature studies employing appropriate sampling protocols, accounting for 
XTC loading dynamics in WWTP influent and effluent (Ort et al., 2010a; 
Majewsky et al., 2011b).  
In the following sections, we will present results from our assessment for the 
antibiotic sulfamethoxazole. Sulfamethoxazole is a widely used antibiotic, 
excreted in parent form (13%–21% of consumed dose) and as N4-acetylated 
(43%–61%) and N1-glucuronide conjugate (10%–13%; see also Figure 1, Pa-
per III). As for other sulfonamide antibiotics, formation of parent sulfameth-
oxazole due to biotransformation of its acetylated metabolite was experimen-
tally observed in water and wastewater (e.g., Radke et al., 2009; Plósz et al., 
2010a). 
6.1 Influence of retransformation 
Figure 6.3 presents the comparison between ηLI and ηTOT predicted with 
ASM-X and measured in a full-scale WWTP, operating at SRT<16 d (Göbel 
et al., 2005, 2007). Measured ηTOT includes the elimination of parent and 
acetylated sulfamethoxazole (CCJ = concentration of N4-acetyl-
sulfamethoxazole in Eq. 6.2), the only measured metabolite.  
ASM-X predictions for both ηLI and ηTOT were found to be rather close to data 
reported by Göbel et al. (2005, 2007). Very low elimination or significant 
formation of sulfamethoxazole (ηLI = -107%–9%) were measured in the full-
scale WWTP, resulting from the almost complete deconjugation of N4-acetyl-
sulfamethoxazole. The graphical evaluation further indicates that retransfor-
mation of sulfamethoxazole occurred mostly in the WWTPs (case 1–2 in Fig. 
6.2). Notably, ηLI significantly underestimated the removal of sulfamethoxa-
zole, which could be instead more adequately described by ηTOT. The under-
estimation error between ηLI and ηTOT in measurements (-160%–44%) was 
close to ASM-X predictions (-200%–60%).  
In addition, the good agreement between full-scale measurements and ASM-
X predictions for ηTOT indicates that the retransformable fraction could be 
completely described by its N4-acetylated conjugate.  Thus, the N1-
glucuronide conjugate may not be relevant for the fate of sulfamethoxazole in 
full-scale WWTPs due to: (i) extensive retransformation in upstream sewers, 
with negligible presence in WWTP influent; or (ii) persistence, and thus lim-
ited retransformation, during biological wastewater treatment. 
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These evidences show the necessity of accounting for retransformable 
metabolites when determining removal efficiencies of XTCs, which would be 
otherwise significantly underestimated. The impact of retransformation in 
full-scale WWTPs, causing this underestimation, was well predicted by 
ASM-X.
 
Figure 6.3. Operating plots showing parent-based (ηLI) and total removal efficiencies 
(ηTOT) for sulfamethoxazole predicted by ASM-X and measured in full-scale systems 
(CAS=conventional activated sludge). Measured ηTOT includes the elimination of 
sulfamethoxazole and its acetylated metabolite. 
 
6.1.1 Retransformation: during biological treatment or in upstream 
sewers? 
In Figure 6.3, we showed that significant retransformation may hinder the 
elimination of parent XTCs—an impact that could be rather well predicted 
with ASM-X. Conversely, investigations in other WWTPs (Radjenovic et al., 
2009; Gurke et al., 2015) reported ηLI > 50%, indicating limited 
retransformation during biological treatment (see Fig. 4a in Paper III). In 
other words, higher removal efficiencies were measured due to significant 
retransformation occurring upstream to the WWTPs assessed (case 3, Fig. 
6.2). It could be thus concluded that processes occurring in upstream sewers 
may influence the elimination of sulfamethoxazole in WWTPs.  
To date, fate in sewer systems (‘reactive sewer’ concept) has been judged 
relevant for: (i) illicit drugs and their metabolites (e.g., Plósz et al., 2013a; 
Ramin et al., in preparation); (ii) estrogens and their conjugates (e.g., Gomes 
et al., 2009; Kumar et al., 2012); and (iii) anti-inflammatory pharmaceuticals 
(Khan and Ongerth, 2004). To our knowledge, scarce information is available 
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on XTCs, in particular on antibiotics. Recently, Jelic et al. (2015) observed 
significant formation of sulfamethoxazole (+ 66%) in pressurized sewers. 
Processes occurring in sewer systems likely influence the removal of parent 
XTCs by changing the WWTP influent composition in terms of parent and 
retransformable fractions, as compared to the typical composition at the ex-
cretion point. Influent composition can be described using the parameter 
nLI,CJ (Plósz et al., 2010a), defined as the ratio between parent (CLI,in) and re-
transformable XTC fractions (CCJ,in) in WWTP influent (Eq. 6.3): 
inCJ
inLI
CJLI C
C
n
,
,
,                        (6.3) 
Furthermore, we hypothesized that the residence time in upstream sewers de-
termines the extent of retransformation, causing differences in nLI,CJ among 
full-scale WWTPs. However, in-sewer residence times are typically not pro-
vided in literature studies, making this hypothesis test challenging. Therefore, 
we assumed that in-sewer residence time may approximated by the design 
capacity of WWTPs (in population equivalent—PE), giving an indication of 
the size of a catchment. As a first tentative confirmation, significant retrans-
formation occurred during wastewater treatment in small/medium WWTPs 
(capacity > 60,000 PE; Göbel at al., 2005; 2007), whereas high ηLI > 50%, 
were observed in large WWTPs (capacity > 250,000 PE; Radjenovic et al., 
2009; Gurke et al., 2015). 
In Figure 6.4, we present nLI,CJ data in WWTP influents (raw and secondary) 
as a function of the design capacity  of the WWTP. Data from a WWTP treat-
ing hospital wastewater (Kovalova et al., 2012) were included to identify a 
scenario with negligible in-sewer transport. To assess the extent of in-sewer 
retransformation, measured nLI,CJ were compared with theoretical ratios at the 
excretion point (Vree et al., 1978; van der Ven et al., 1994). Data from mu-
nicipal full-scale WWTPs (capacity > 10,000 PE) confirmed our hypothesis, 
showing relative increase of parent sulfamethoxazole content in influent with 
increasing WWTP capacity.  
Unexpectedly, rather high nLI,CJ were reported for the hospital catchment. 
This finding may be explained by the excretion of hospitalized patients. Even 
if pharmaceuticals are administered in hospitals, significant fractions are ex-
creted in households due to reduced hospitalization period (Ort et al., 2010b). 
In addition, pharmacokinetic studies reported a slower elimination of acety-
lated sulfamethoxazole from human body than of parent sulfamethoxazole 
58 
(Vree and Hekster, 1987; van der Ven et al., 1994; Vree et al., 1995). Alto-
gether, this seems to justify the observation of higher nLI,CJ in hospital sew-
age. 
In summary, retransformation of the acetylated metabolite can significantly 
influence the observable removal of sulfamethoxazole in full-scale WWTPs. 
The size and the type of catchment (hospital or municipal) further determine 
whether retransformation is expected during wastewater treatment or in up-
stream sewers, justifying the variability of elimination data reported in litera-
ture. 
Figure 6.4. Influence of catchment size (indicated by WWTP design capacity) on in-sewer 
retransformation of conjugates back to parent sulfamethoxazole (PI = primary influent; SI 
= secondary influent). 
 
6.2 Influence of SRT 
Figure 6.5 presents ηLI and ηTOT predictions and measurements in full-scale 
WWTPs operating at SRT>16 d, including a biofilm system (fixed bed reac-
tor—FBR). Negative ηLI were found (-138% and -61%), possibly resulting 
from high loads of N4-acetyl-sulfamethoxazole (nLI,CJ=0.15) in secondary in-
fluent and thus extensive retransformation. 
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Nevertheless, these measurements represented an exception, and measured ηLI 
and ηTOT were overall significantly higher than in Figure 6.2. Specifically, 
enhanced elimination was shown in the MBR (ηLI=37%-40%; ηTOT=70%–
90%) under the same loading conditions of CAS 1 (Fig. 6.3). Full-scale data 
points for ηLI and ηTOT were accordingly above the respective prediction 
curves (Fig. 6.5), indicating improved elimination at extended SRT (case 4, 
Fig. 6.2). 
Enhanced biotransformation of sulfamethoxazole at extended SRT was 
considered to cause these observations, and predictions at kbio = 3 L gTSS-1 d-
1 were used to describe a maximum removal scenario (Fig. 6.5). A step 
increase of kbio beyond a specific SRT value was assumed to describe 
enhanced XTC biotransformation according to Plósz et al. (2012), as a result 
of e.g., enrichment of specialist degrader populations or metabolic expansion. 
This is in agreement with observations in MBR by Göbel et al. (2007), who 
found no ηLI and ηTOT increase with increasing SRT. 
 
Figure 6.5. Operating plots showing parent-based (ηLI) and total removal efficiencies 
(ηTOT) for sulfamethoxazole predicted by ASM-X and measured in full-scale systems. 
Measured ηTOT includes the elimination of sulfamethoxazole and its acetylated metabolite. 
Scenario simulations to predicted ηLI and ηTOT at extended SRT (‘High SRT’ curves) were 
run assuming kbio = 3 L gTSS-1 d-1. 
 
To date, laboratory- and pilot-scale studies have provided for controversial 
results for systems at extended SRT. In MBR systems, enhancement of 
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sulfamethoxazole biotransformation was not reported (Abegglen et al., 2009; 
Fernandez-Fontaina et al., 2013; SRT > 100 d), and improved removal was 
rather attributed to operation at high TSS concentrations (Sahar et al., 2011). 
In Paper II, conversely, we showed that kbio > 1 L gTSS-1 d-1 were obtained 
for sulfamethoxazole in pre-denitrifying MBBR, being significantly higher 
than rate constants for suspended growth systems (Fig. 5.3; see also Table S4 
in Paper III).  
The presented model-based assessment revealed the possibility for enhanced 
elimination of sulfamethoxazole in full-scale high SRT WWTPs. Whether 
this should be associated to a kinetic improvement of biotransformation, it 
could be proved only for biofilm systems (Paper II). 
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7 Beyond WWTPs: fate of XTCs in 
agricultural systems 
Removal via biodegradation of XTCs in conventional WWTPs is generally 
incomplete, with consequent release with WWTP effluents and/or accumula-
tion in sewage sludge. Significant XTCs emissions thus occur (i) to freshwa-
ter bodies, receiving WWTP effluents; and (ii) to agricultural soils, due to 
fertilization with sewage sludge. In the European Union, reuse of sewage 
sludge as fertilizer is a practice encouraged by the 86/278/EEC Directive. 
At regulatory level, the risk posed by the environmental release of XTCs has 
been acknowledged through the application of the regulation (EC) 
1907/2006, also known as REACH (Registration, Evaluation, Authorisation 
and Restriction of Chemicals). Environmental risk assessment strategies have 
been accordingly implemented for the prioritization of marketed chemicals. 
Chemical prioritization is based on prediction of environmental exposure as-
sociated toxicity effects in environmental media (e.g., freshwater, agricultural 
soil).    
Besides application of sewage sludge, XTC emissions to agricultural soils 
occur due to irrigation with freshwater and treated WWTP effluent (Ternes et 
al., 2007; Calderón-Preciado et al., 2011). Overall, these practices may lead 
to the uptake and subsequent accumulation of XTCs in food crops, with un-
clear effects for human health due to dietary intake (Prosser and Sibley, 2015; 
Malchi et al., 2015). Assessing the fate of XTCs in agricultural systems is a 
largely uninvestigated subject, particularly in the European Union.  
In Paper IV, we developed and applied a generic simulation system to pre-
dict the fate of ionizable XTCs from consumption/excretion to the accumula-
tion in food crops (namely, winter wheat). Three ionizable XTCs were select-
ed (triclosan, furosemide, ciprofloxacin), for which realistic emission data for 
different areas in the European Union were used. In the following sections, 
we will give a brief description of the simulation system and of most relevant 
predictions in terms of plant uptake. 
7.1 A generic fate modelling framework 
Three subsequent steps were considered in predicting the fate of XTCs (Fig. 
7.1): (i) household consumption and excretion to sewer systems; (ii) elimina-
tion in municipal WWTP; and (iii) fate in agricultural systems, following 
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emissions to soil via fertilization with sewage sludge or irrigation with 
freshwater. The generic modelling framework combined the WWTP model 
Activity SimpleTreat (Franco et al., 2011; see 3.1) and the dynamic soil-plant 
model (Legind et al., 2012; Trapp and Eggen, 2013; see 3.4). A time interval 
of two consecutive years with fertilization or irrigation was used to simulate 
XTC uptake into wheat. 
Published XTC consumption/emission data and environmental conditions 
(e.g., precipitation) were used as input for predictions in four different geo-
graphical areas of the European Union (Germany, Denmark, Sweden and Ita-
ly). Model predictions were eventually validated with measured data—when 
available—from the geographical areas of the European Union.  
Significant variability is often associated to XTC properties used as input in 
fate models, e.g., excreted fractions (Ort et al., 2009) and biodegradation 
rates (e.g., Franco and Trapp, 2009). In Paper IV, input parameters were de-
rived from literature, and reported parameter variability was accounted for as 
a source of uncertainty in model predictions. A Monte Carlo-based approach, 
adapted from Sin et al. (2009), was used to determine the uncertainty propa-
gation to model output.  
 
Figure 7.1. System boundaries for fate prediction of TCS, FUR and CIP from consumption 
to uptake into winter wheat. The time frame for sludge application and irrigation scenarios 
are reported (full arrows: Italian scenario; dashed arrows: Danish scenario).  
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Fate predictions for triclosan, furosemide and ciprofloxacin were reported, 
compared and tentatively validated in Figures 2–5 of Paper IV. An example 
is presented here for furosemide in the Danish scenario (Fig. 7.2). Furo-
semide is a highly consumed pharmaceutical in Denmark (medstat.dk), with 
estimated emissions of more than 500 g 1000cap-1 a-1 to urban WWTPs. Neg-
ligible sorption of furosemide to sludge was predicted, due to its low lipo-
philicity and its speciation as anion at wastewater pH (pKa=3.34–3.90). Lim-
ited WWTP elimination was accordingly shown, resulting in significant 
emissions to freshwater. A significant fraction of emissions to soil (0.28 ± 
0.07 g ha-1 a-1) was predicted to be uptaken in winter wheat (48.9%). Signifi-
cant uncertainty was associated to fractions uptaken in plant compartment (up 
to 80% relative standard deviation). 
 
Figure 7.2. Fate prediction in the generic WWTP and agricultural system for furosemide in 
the Danish scenario, with freshwater irrigation. Input to WWTP and soil-plant system is 
presented in g 1000cap-1 a-1 and g ha-1 a-1, respectively. Output mass loads in the generic 
WWTP and in the soil-plant system are presented as % fraction of input load. Model pre-
dictions are presented as mean ± standard deviation of 50,000 Monte Carlo simulations.  
 
7.2 Uptake in winter wheat 
Model predictions showed significantly different plant uptake for the three 
ionizable XTCs selected (Fig. 7.3), assuming negligible in planta degrada-
tion. Limited translocation of triclosan (<1% of emissions to soil) was pre-
dicted, resulting from low half-life observed in soil (13–110 d; Xu et al., 
2009; Walters et al., 2010). Strong binding to soil matrix determined the neg-
ligible plant uptake (<0.1 % of emissions to soil) predicted for ciprofloxacin.  
Biodegraded:
26.7% ± 11.7% Effluent:
72.5% ± 11.6%
Sludge:
0.7% ± 0.1%
Leaf:
1.9% ± 1.5%
Grain: 
4.6% ± 3.5%
Stem:
3.8% ± 2.3%
Leaching:
1.1% ± 0.4%
Roots: 
38.5% ± 4.5%
Irrigation:
0.28 ± 0.07
g ha-1 a-1Influent:
520.8 ± 101.0
g 1000PE-1 a-1
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Conversely, major translocation of furosemide (on average, >25% of emis-
sions to soil) was predicted. As a polar chemical (pKa=3.34–3.90; 
logKow=1.90–2.32), furosemide undergoes little partitioning in soil (Franco 
and Trapp, 2008; Franco et al., 2009) and can be co-transported with water 
into wheat plants. Most of in planta accumulation was shown in wheat roots, 
resulting from high affinity of furosemide to proteins (logKa,HSA>5; 
ACD/DBP, ilab.acdlabs.com). Notably, the overall fraction accumulated in 
whole wheat plant was found significantly higher in the irrigation scenario 
(48.9%), as compared to sludge application (27.6%). Irrigation occurs in 
proximity to plant harvest, when growing wheat plants take up high amounts 
of soil pore water, whereas fertilization is assumed to take place in September 
(Fig. 7.1). 
Relevant accumulation in wheat grain was accordingly shown only for furo-
semide (4.2%–4.6% of emission to soil). Differences between XTCs were 
further highlighted when calculating bioconcentration factors to wheat grain 
(BCFgrain, kgDW kgDW-1; Eq. 7.1): 
BCFgrain = Cgrain(harvest) / Csoil(amendment)           (7.1) 
where Csoil(amendment) denotes XTC concentration in the top soil layer at 
sludge amendment or at the last irrigation pulse. Highest BCFgrain was pre-
dicted for furosemide (< 10 kgDW kgDW-1), with limited uptake for triclosan 
and ciprofloxacin (< 0.1 kgDW kgDW-1). Significant uncertainty (up to 12-fold 
5th–95th percentile variation) was associated to BCFgrain predictions. 
Uptake of furosemide into wheat grain is likely associated to its ionization pat-
tern. At phloem pH (=8), furosemide is present as anion and thus undergoes ion 
trapping (Trapp, 2004, 2009), with transport via transpiration from stem to 
grains. Although no empirical confirmation of the uptake of furosemide exists, 
ion trapping may explain the significant uptake into plants (and fruits) of other 
polar weak acids, namely herbicides (Trapp, 2009) and anti-inflammatory phar-
maceuticals (e.g., naproxen; Goldstein et al., 2014). 
Predictions of uptake into food crops, and specifically to edible plant tissues, are 
highly relevant for the estimation of human dietary intake and consequent expo-
sure to XTCs. Based on modelling results presented here, low-to-negligible risk 
was associated to the dietary intake of triclosan, furosemide and ciprofloxacin. 
Nevertheless, our model predictions provide evidence only for wheat grain, and 
investigations on other highly consumed food crops may be required. 
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Figure 7.3. Predicted relative translocation to wheat tissues (bars, left y axis) and BCFgrain 
(box plot, right y axis) for triclosan (Denmark—DK, sludge application), furosemide 
(Denmark—DK, sludge application and irrigation) and ciprofloxacin (Italy—ITA, sludge 
application). Box plots refer to the uncertainty of simulated model scenarios and include 
mean values (red dotted lines) and 5th and 95th (red crosses), 10th and 90th (error bars), 25th, 
50th and 75th percentiles (boxes). 
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8 Conclusions 
This PhD thesis contributed to improve the understanding of the fate of xeno-
biotic trace chemicals (XTCs) during and beyond wastewater treatment. 
Through model-based interpretation of experimental observations, and by 
developing and testing a number of modelling tools, our research provided 
for evidences on: (i) the influence of pH and iron salt dosing on the partition-
ing of zwitterionic XTCs; (ii) the influence of primary metabolism on the 
biological transformation of XTCs in MBBR biofilm; (iii) the significance of 
retransformation and solid residence time on the elimination of the antibiotic 
sulfamethoxazole; and (iv) the potential accumulation in food crops of XTCs 
released from wastewater treatment plants (WWTPs) via biosolids amend-
ment and freshwater irrigation. To reach the major conclusions of our re-
search, fate modelling was considered from different aspects, namely model 
development, model identification, model validation and uncertainty analysis.  
First, this research showed that pH conditions and, to a lesser extent, iron salt 
dosing for chemical treatment processes can dramatically impact solid-liquid 
partitioning of zwitterionic XTCs onto activated sludge. This influence was 
found substantial for the zwitterionic antibiotic ciprofloxacin, suggesting that 
partitioning results mainly from electrostatic interactions between charged 
XTCs and charged sludge surfaces. The highest sorption capacity was shown 
for ciprofloxacin zwitterion, capable of partitioning via multiple electrostatic 
interactions (cation exchange, cation bridging, surface complexation). Signif-
icant sorption capacity was associated to ciprofloxacin cation, whereas sorp-
tion of the anion was negligible due to prevailing Coulombic repulsion with 
negatively charged sludge surfaces. An extension to traditional partitioning 
models was proposed to account for XTC ionization with changing pH and 
different sorption potential of ionized species. Such extension could be bene-
ficial: (i) to predict the partitioning of other XTCs having similar ionization 
patterns (e.g., fluoroquinolones, tetracyclines), thus ionizing into more than 
one species at typical sewage pH; (i) when explicitly incorporating pH pre-
diction tools in WWTP models. 
Secondly, we investigated biological transformation kinetics of XTCs in pre-
denitrifying MBBRs operated in single-stage and three-stage configurations. 
Model identification was a crucial step in characterizing biotransformation of 
indigenous XTCs in real wastewater. Model equations were successfully test-
ed to describe enantioselective biotransformation and retransformation of 
e.g., XTC conjugates. Based on model-based observations, we demonstrated 
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that biofilm exposure to different electron donor (i.e., COD for nitrogen ox-
ide reduction) loading and availability conditions influenced XTC biotrans-
formation kinetics in MBBRs. Specifically, denitrifying biofilm developed 
increasing capacity of biodegrading XTC as a function of COD loading con-
ditions in the three-stage MBBR. Correlation between biotransformation rate 
constants and denitrification potential was found, indicating that XTC degra-
dation occurred via cometabolism. These evidences provided insights on the 
fate of XTCs under denitrifying conditions, and support the employment of 
innovative design concepts to improve XTC elimination during biological 
wastewater treatment.  
Thirdly, by comparing model predictions and literature data, we could 
demonstrate that the elimination of the antibiotic sulfamethoxazole in full-
scale WWTPs is influenced by retransformation of conjugated metabolites 
and SRT. Through the Activated Sludge Modelling framework for Xenobiot-
ics (ASM-X) it was possible to adequately predict the extent of these impacts. 
A critical SRT of 16 d was identified to improve the elimination of sulfa-
methoxazole, possibly confirming our experimental observations of enhanced 
biotransformation in MBBRs. Importantly, retransformation can prevail in 
sewers upstream to municipal WWTPs. Therefore, we showed that the 
catchment size can determine whether retransformation is more significant 
during secondary wastewater treatment (small catchments) or in upstream 
sewers (large catchments), thereby influencing the observed removal effi-
ciency in WWTPs. This rule was not applicable to hospital WWTPs (‘zero-
catchment’) due to temporal excretion trends by hospitalized patients. Over-
all, these findings call for an integrated approach: (i) with respect to XTCs, 
by evaluating parent and retransformable fractions; (ii) at the system bounda-
ry level, by incorporating excretion and in-sewer fate processes in the evalu-
ating XTC removal. 
Eventually, a generic modelling tool was developed and tested to predict the 
fate of ionizable XTCs from consumption and excretion to the uptake in food 
crops, through the elimination in WWTPs. Among the XTCs selected, the 
diuretic furosemide was predicted to be particularly recalcitrant to wastewater 
treatment, in agreement with peer-reviewed literature. As a polar, anionic 
XTC, furosemide was also predicted to undergo significant accumulation in 
wheat (30%–50% of emission to soil). Freshwater irrigation enhanced the 
relative uptake of furosemide in wheat as compared to fertilization with bio-
solids. This evidence is particularly relevant to the increasingly frequent re-
use of reclaimed water for crop irrigation. The developed modelling tool is 
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intended to be used: (i) for priority setting, e.g., providing estimations of hu-
man exposure to XTCs via dietary intake; (ii) to identify experimental re-
search needs, i.e. fate assessment of potentially hazardous XTCs in agricul-
tural systems; and (iii) to predict accumulation in food crops following XTC 
emissions via alternative pathways, e.g., irrigation with reclaimed wastewater 
or manure application. 
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